BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857-866. [PMID: 17060945 DOI: 10.1038/nrc1997] [Cited by in Crossref: 5257] [Cited by in F6Publishing: 5097] [Article Influence: 375.5] [Reference Citation Analysis]
Number Citing Articles
1 Shi Y, Wang Y, Luan W, Wang P, Tao T, Zhang J, Qian J, Liu N, You Y. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS One. 2014;9:e86295. [PMID: 24466011 DOI: 10.1371/journal.pone.0086295] [Cited by in Crossref: 185] [Cited by in F6Publishing: 206] [Article Influence: 26.4] [Reference Citation Analysis]
2 Liu X, Chu KM. Molecular biomarkers for prognosis of gastrointestinal stromal tumor. Clin Transl Oncol 2019;21:145-51. [PMID: 30003531 DOI: 10.1007/s12094-018-1914-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
3 Smallridge RC, Marlow LA, Copland JA. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer 2009;16:17-44. [PMID: 18987168 DOI: 10.1677/ERC-08-0154] [Cited by in Crossref: 251] [Cited by in F6Publishing: 129] [Article Influence: 19.3] [Reference Citation Analysis]
4 Jin F, Wang Y, Li M, Zhu Y, Liang H, Wang C, Wang F, Zhang CY, Zen K, Li L. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy. Cell Death Dis. 2017;8:e2540. [PMID: 28079894 DOI: 10.1038/cddis.2016.461] [Cited by in Crossref: 97] [Cited by in F6Publishing: 113] [Article Influence: 24.3] [Reference Citation Analysis]
5 Garajová I, Le Large TY, Frampton AE, Rolfo C, Voortman J, Giovannetti E. Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer. Biomed Res Int. 2014;2014:678401. [PMID: 25250326 DOI: 10.1155/2014/678401] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
6 Lin Y, Liu AY, Fan C, Zheng H, Li Y, Zhang C, Wu S, Yu D, Huang Z, Liu F, Luo Q, Yang CJ, Ouyang G. MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1. Sci Rep 2015;5:9995. [PMID: 25919570 DOI: 10.1038/srep09995] [Cited by in Crossref: 92] [Cited by in F6Publishing: 95] [Article Influence: 15.3] [Reference Citation Analysis]
7 Hong L, Ya-wei L, Hai W, Qiang Z, Jun-jie L, Huang A, Song-tao Q, Yun-tao L. MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway. J Neurooncol 2016;128:35-45. [DOI: 10.1007/s11060-016-2095-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
8 Long G, Wang F, Duan Q, Yang S, Chen F, Gong W, Yang X, Wang Y, Chen C, Wang DW. Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS One. 2012;7:e50926. [PMID: 23236408 DOI: 10.1371/journal.pone.0050926] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 9.3] [Reference Citation Analysis]
9 Plieskatt JL, Rinaldi G, Feng Y, Levine PH, Easley S, Martinez E, Hashmi S, Sadeghi N, Brindley PJ, Bethony JM, Mulvenna JP. Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma. J Transl Med 2014;12:3. [PMID: 24393330 DOI: 10.1186/1479-5876-12-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
10 Ulivi P, Petracci E, Marisi G, Baglivo S, Chiari R, Billi M, Canale M, Pasini L, Racanicchi S, Vagheggini A, Delmonte A, Mariotti M, Ludovini V, Bonafè M, Crinò L, Grignani F. Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer. J Clin Med 2019;8:E131. [PMID: 30678026 DOI: 10.3390/jcm8020131] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
11 Papagiannakopoulos T, Kosik KS. MicroRNAs: regulators of oncogenesis and stemness. BMC Med. 2008;6:15. [PMID: 18577221 DOI: 10.1186/1741-7015-6-15] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 5.9] [Reference Citation Analysis]
12 Singh NP, Singh UP, Guan H, Nagarkatti P, Nagarkatti M. Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression. PLoS One 2012;7:e45054. [PMID: 23024791 DOI: 10.1371/journal.pone.0045054] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
13 Liu W, Wang S, Zhou S, Yang F, Jiang W, Zhang Q, Wang L. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells. Mol BioSyst 2017;13:2268-76. [DOI: 10.1039/c7mb00362e] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 Zhu M, Zhang N, Lu X, He S. Negative Regulation of Kruppel-Like Factor 4 on microRNA-106a at Upstream Transcriptional Level and the Role in Gastric Cancer Metastasis. Dig Dis Sci 2018;63:2604-16. [PMID: 29948558 DOI: 10.1007/s10620-018-5143-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cole K, Tabernero M, Anderson KS. Biologic characteristics of premalignant breast disease. Cancer Biomark 2010;9:177-92. [PMID: 22112476 DOI: 10.3233/CBM-2011-0187] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ni H, Dai X, Leng X, Deng M, Qin Y, Ji Q, Xu C, Li J, Liu Y. Higher variety and quantity of microRNA-139-5p isoforms confer suppressive role in hepatocellular carcinoma. J Cell Biochem 2018;119:6806-13. [PMID: 29693285 DOI: 10.1002/jcb.26874] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
17 Tsukerman P, Yamin R, Seidel E, Khawaled S, Schmiedel D, Bar-Mag T, Mandelboim O. MiR-520d-5p directly targets TWIST1 and downregulates the metastamiR miR-10b. Oncotarget 2014;5:12141-50. [PMID: 25426550 DOI: 10.18632/oncotarget.2559] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
18 Li Y, Zhang D, Chen C, Ruan Z, Li Y, Huang Y. MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. Mol Biol Cell 2012;23:1423-34. [PMID: 22357618 DOI: 10.1091/mbc.E11-09-0777] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
19 Benz F, Tacke F, Luedde M, Trautwein C, Luedde T, Koch A, Roderburg C. Circulating microRNA-223 serum levels do not predict sepsis or survival in patients with critical illness. Dis Markers 2015;2015:384208. [PMID: 25810564 DOI: 10.1155/2015/384208] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
20 Tang H, Liu X, Wang Z, She X, Zeng X, Deng M, Liao Q, Guo X, Wang R, Li X, Zeng F, Wu M, Li G. Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth. Brain Res. 2011;1390:21-32. [PMID: 21435336 DOI: 10.1016/j.brainres.2011.03.034] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 6.9] [Reference Citation Analysis]
21 Chen W, Li S. Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease. Pediatr Cardiol 2017;38:86-94. [DOI: 10.1007/s00246-016-1487-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
22 Chen X, Li TH, Zhao Y, Wang CC, Zhu CC. Deep-belief network for predicting potential miRNA-disease associations. Brief Bioinform 2021;22:bbaa186. [PMID: 34020550 DOI: 10.1093/bib/bbaa186] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
23 Link A, Becker V, Goel A, Wex T, Malfertheiner P. Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer. PLoS One. 2012;7:e42933. [PMID: 22905187 DOI: 10.1371/journal.pone.0042933] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
24 Chu LY, Peng YH, Weng XF, Xie JJ, Xu YW. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma. World J Gastroenterol 2020; 26(15): 1708-1725 [PMID: 32351288 DOI: 10.3748/wjg.v26.i15.1708] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Pu XX, Huang GL, Guo HQ, Guo CC, Li H, Ye S, Ling S, Jiang L, Tian Y, Lin TY. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol. 2010;25:1674-1680. [PMID: 20880178 DOI: 10.1111/j.1440-1746.2010.06417.x] [Cited by in Crossref: 206] [Cited by in F6Publishing: 211] [Article Influence: 20.6] [Reference Citation Analysis]
26 Liu M, Tang Q, Qiu M, Lang N, Li M, Zheng Y, Bi F. miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett. 2011;585:2998-3005. [PMID: 21872591 DOI: 10.1016/j.febslet.2011.08.014] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 7.0] [Reference Citation Analysis]
27 De Leeneer K, Claes K. Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer. Adv Exp Med Biol 2015;867:263-75. [PMID: 26530371 DOI: 10.1007/978-94-017-7215-0_16] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
28 Arbuthnot P, Thompson LJ. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1670-1681 [PMID: 18350598 DOI: 10.3748/wjg.14.1670] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
29 Zuntini M, Salvatore M, Pedrini E, Parra A, Sgariglia F, Magrelli A, Taruscio D, Sangiorgi L. MicroRNA profiling of multiple osteochondromas: identification of disease-specific and normal cartilage signatures. Clin Genet 2010;78:507-16. [PMID: 20662852 DOI: 10.1111/j.1399-0004.2010.01490.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
30 Potenza N, Mosca N, Mondola P, Damiano S, Russo A, De Felice B. Human miR-26a-5p regulates the glutamate transporter SLC1A1 (EAAT3) expression. Relevance in multiple sclerosis. Biochim Biophys Acta Mol Basis Dis 2018;1864:317-23. [PMID: 28962897 DOI: 10.1016/j.bbadis.2017.09.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
31 Kushlinskii NE, Fridman MV, Braga EA. Molecular mechanisms and microRNAs in osteosarcoma pathogenesis. Biochemistry Moscow 2016;81:315-28. [DOI: 10.1134/s0006297916040027] [Cited by in Crossref: 63] [Cited by in F6Publishing: 47] [Article Influence: 12.6] [Reference Citation Analysis]
32 Liu RY, Diao CF, Zhang Y, Wu N, Wan HY, Nong XY, Liu M, Tang H. miR-371-5p down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma cells. Cancer Lett 2013;335:351-60. [PMID: 23466643 DOI: 10.1016/j.canlet.2013.02.045] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
33 Schwind S, Maharry K, Radmacher MD, Mrózek K, Holland KB, Margeson D, Whitman SP, Hickey C, Becker H, Metzeler KH, Paschka P, Baldus CD, Liu S, Garzon R, Powell BL, Kolitz JE, Carroll AJ, Caligiuri MA, Larson RA, Marcucci G, Bloomfield CD. Prognostic Significance of Expression of a Single MicroRNA, miR-181a , in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study. JCO 2010;28:5257-64. [DOI: 10.1200/jco.2010.29.2953] [Cited by in Crossref: 140] [Cited by in F6Publishing: 88] [Article Influence: 12.7] [Reference Citation Analysis]
34 Tong AW, Nemunaitis J. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther. 2008;15:341-355. [PMID: 18369380 DOI: 10.1038/cgt.2008.8] [Cited by in Crossref: 159] [Cited by in F6Publishing: 152] [Article Influence: 12.2] [Reference Citation Analysis]
35 Zhou J, Tao Y, Peng C, Gu P, Wang W. miR-503 regulates metastatic function through Rho guanine nucleotide exchanger factor 19 in hepatocellular carcinoma. J Surg Res 2014;188:129-36. [PMID: 24405610 DOI: 10.1016/j.jss.2013.12.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
36 Yu DC, Li QG, Ding XW, Ding YT. Circulating MicroRNAs: Potential Biomarkers for Cancer. Int J Mol Sci. 2011;12:2055-2063. [PMID: 21673939 DOI: 10.3390/ijms12032055] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
37 Kita Y, Vincent K, Natsugoe S, Berindan-Neagoe I, Calin GA. Epigenetically regulated microRNAs and their prospect in cancer diagnosis. Expert Rev Mol Diagn 2014;14:673-83. [PMID: 24914586 DOI: 10.1586/14737159.2014.925399] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
38 Sun L, Wang L, Chen T, Yao B, Wang Y, Li Q, Yang W, Liu Z. microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC. J Cell Mol Med 2019;23:8292-304. [PMID: 31576658 DOI: 10.1111/jcmm.14705] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
39 Hotchi M, Shimada M, Kurita N, Iwata T, Sato H, Morimoto S, Yoshikawa K, Higashijima J, Miyatani T. microRNA expression is able to predict response to chemoradiotherapy in rectal cancer. Mol Clin Oncol. 2013;1:137-142. [PMID: 24649136 DOI: 10.3892/mco.2012.9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
40 Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G, Taccioli C, Liu CG, Croce CM, Condorelli G. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene. 2008;27:3845-3855. [PMID: 18246122 DOI: 10.1038/onc.2008.6] [Cited by in Crossref: 180] [Cited by in F6Publishing: 189] [Article Influence: 13.8] [Reference Citation Analysis]
41 Liu Y, Zhang Y, Wen J, Liu L, Zhai X, Liu J, Pan S, Chen J, Shen H, Hu Z. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS One 2012;7:e32230. [PMID: 22393390 DOI: 10.1371/journal.pone.0032230] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
42 Russ R, Slack FJ. Cigarette-Smoke-Induced Dysregulation of MicroRNA Expression and Its Role in Lung Carcinogenesis. Pulm Med 2012;2012:791234. [PMID: 22191027 DOI: 10.1155/2012/791234] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
43 Finch ML, Marquardt JU, Yeoh GC, Callus BA. Regulation of microRNAs and their role in liver development, regeneration and disease. Int J Biochem Cell Biol. 2014; Apr 13. [Epub ahead of print]. [PMID: 24731940 DOI: 10.1016/j.biocel.2014.04.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
44 Chen Y, Jacquemin T, Zhang S, Jiang R. Prioritizing protein complexes implicated in human diseases by network optimization. BMC Syst Biol 2014;8 Suppl 1:S2. [PMID: 24565064 DOI: 10.1186/1752-0509-8-S1-S2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
45 Zhang Z, Zhu Z, Watabe K, Zhang X, Bai C, Xu M, Wu F, Mo YY. Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ 2013;20:1558-68. [PMID: 23933812 DOI: 10.1038/cdd.2013.110] [Cited by in Crossref: 269] [Cited by in F6Publishing: 276] [Article Influence: 33.6] [Reference Citation Analysis]
46 Tóth K, Barták BK, Tulassay Z, Molnár B. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis. Expert Rev Mol Diagn 2016;16:239-52. [PMID: 26652067 DOI: 10.1586/14737159.2016.1132164] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
47 Massari F, Ciccarese C, Santoni M, Brunelli M, Conti A, Modena A, Montironi R, Santini D, Cheng L, Martignoni G, Cascinu S, Tortora G. The route to personalized medicine in bladder cancer: where do we stand? Targ Oncol 2015;10:325-36. [DOI: 10.1007/s11523-015-0357-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
48 Pandita A, Manvati S, Singh SK, Vaishnavi S, Bamezai RN. Combined effect of microRNA, nutraceuticals and drug on pancreatic cancer cell lines. Chemico-Biological Interactions 2015;233:56-64. [DOI: 10.1016/j.cbi.2015.03.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
49 Fathi-Kazerooni M, Kazemnejad S, Khanjani S, Saltanatpour Z, Tavoosidana G. Down-regulation of miR-122 after transplantation of mesenchymal stem cells in acute liver failure in mice model. Biologicals 2019;58:64-72. [PMID: 30824230 DOI: 10.1016/j.biologicals.2019.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Zhu Y, Luo M, Brooks M, Clouthier SG, Wicha MS. Biological and clinical significance of cancer stem cell plasticity. Clin Transl Med 2014;3:32. [PMID: 26932376 DOI: 10.1186/s40169-014-0032-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
51 Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, Lopes B, Schiff D, Purow B, Abounader R. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009;69:7569-7576. [PMID: 19773441 DOI: 10.1158/0008-5472.can-09-0529] [Cited by in Crossref: 425] [Cited by in F6Publishing: 263] [Article Influence: 35.4] [Reference Citation Analysis]
52 Zhang L, Qin C, Mei J, Chen X, Wu Z, Luo X, Cheng J, Tang X, Hu K, Li SC. Identification of MicroRNA Targets of Capsicum spp. Using MiRTrans-a Trans-Omics Approach. Front Plant Sci 2017;8:495. [PMID: 28443105 DOI: 10.3389/fpls.2017.00495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Mai D, Ding P, Tan L, Zhang J, Pan Z, Bai R, Li C, Li M, Zhou Y, Tan W, Zhou Z, Li Y, Zhou A, Ye Y, Pan L, Zheng Y, Su J, Zuo Z, Liu Z, Zhao Q, Li X, Huang X, Li W, Wu S, Jia W, Zou S, Wu C, Xu RH, Zheng J, Lin D. PIWI-interacting RNA-54265 is oncogenic and a potential therapeutic target in colorectal adenocarcinoma. Theranostics 2018;8:5213-30. [PMID: 30555542 DOI: 10.7150/thno.28001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 16.3] [Reference Citation Analysis]
54 Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA. 2007;104:15805-15810. [PMID: 17890317 DOI: 10.1073/pnas.0707628104] [Cited by in Crossref: 1174] [Cited by in F6Publishing: 1107] [Article Influence: 83.9] [Reference Citation Analysis]
55 Chen X, Cheng JY, Yin J. Predicting microRNA-disease associations using bipartite local models and hubness-aware regression. RNA Biol 2018;15:1192-205. [PMID: 30196756 DOI: 10.1080/15476286.2018.1517010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
56 Martino S, di Girolamo I, Orlacchio A, Datti A, Orlacchio A. MicroRNA implications across neurodevelopment and neuropathology. J Biomed Biotechnol 2009;2009:654346. [PMID: 19841678 DOI: 10.1155/2009/654346] [Cited by in Crossref: 31] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
57 Fantini S, Salsi V, Reggiani L, Maiorana A, Zappavigna V. The miR-196b miRNA inhibits the GATA6 intestinal transcription factor and is upregulated in colon cancer patients. Oncotarget 2017;8:4747-59. [PMID: 27902469 DOI: 10.18632/oncotarget.13580] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
58 Shinden Y, Iguchi T, Akiyoshi S, Ueo H, Ueda M, Hirata H, Sakimura S, Uchi R, Takano Y, Eguchi H, Sugimachi K, Kijima Y, Natsugoe S, Mimori K. miR-29b is an indicator of prognosis in breast cancer patients. Mol Clin Oncol 2015;3:919-23. [PMID: 26171207 DOI: 10.3892/mco.2015.565] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
59 Motawi TK, Rizk SM, Ibrahim TM, Ibrahim IA. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis. Cell Biochem Funct 2016;34:142-8. [PMID: 26916216 DOI: 10.1002/cbf.3171] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
60 Yan L, Ding B, Liu H, Zhang Y, Zeng J, Hu J, Yao W, Yu G, An R, Chen Z, Ye Z, Xing J, Xiao K, Wu L, Xu H. Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma. Theranostics 2019;9:8377-91. [PMID: 31754403 DOI: 10.7150/thno.37628] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
61 Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, Detmar M, Gay S, Kyburz D. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58:1001-1009. [PMID: 18383392 DOI: 10.1002/art.23386] [Cited by in Crossref: 580] [Cited by in F6Publishing: 555] [Article Influence: 44.6] [Reference Citation Analysis]
62 Yoo JY, Yeh M, Wang YY, Oh C, Zhao ZM, Kaur B, Lee TJ. MicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin. Biomedicines 2021;9:780. [PMID: 34356844 DOI: 10.3390/biomedicines9070780] [Reference Citation Analysis]
63 Zeng F, Xue M, Xiao T, Li Y, Xiao S, Jiang B, Ren C. MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1. Biomed Pharmacother 2016;79:294-301. [PMID: 27044840 DOI: 10.1016/j.biopha.2016.02.033] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
64 Liu F, Tian T, Xia LL, Ding Y, Cormier RT, He Y. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update. Dis Esophagus 2017;30:1-9. [PMID: 27003597 DOI: 10.1111/dote.12489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
65 Wild CP. Environmental exposure measurement in cancer epidemiology. Mutagenesis 2009;24:117-25. [PMID: 19033256 DOI: 10.1093/mutage/gen061] [Cited by in Crossref: 100] [Cited by in F6Publishing: 85] [Article Influence: 7.7] [Reference Citation Analysis]
66 Saito Y, Nakaoka T, Saito H. A New Molecular Mechanism Underlying the Antitumor Effect of DNA Methylation Inhibitors via an Antiviral Immune Response. Chromatin Remodelling and Immunity. Elsevier; 2017. pp. 227-42. [DOI: 10.1016/bs.apcsb.2016.08.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
67 Pascale A, Govoni S. The complex world of post-transcriptional mechanisms: is their deregulation a common link for diseases? Focus on ELAV-like RNA-binding proteins. Cell Mol Life Sci 2012;69:501-17. [PMID: 21909784 DOI: 10.1007/s00018-011-0810-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
68 Ma L, Shao Z, Zhao Y. MicroRNA-374a promotes pancreatic cancer cell proliferation and epithelial to mesenchymal transition by targeting SRCIN1. Pathology - Research and Practice 2019;215:152382. [DOI: 10.1016/j.prp.2019.03.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
69 Ghaedi H, Bastami M, Jahani MM, Alipoor B, Tabasinezhad M, Ghaderi O, Nariman-saleh-fam Z, Mirfakhraie R, Movafagh A, Omrani MD, Masotti A. A Bioinformatics Approach to the Identification of Variants Associated with Type 1 and Type 2 Diabetes Mellitus that Reside in Functionally Validated miRNAs Binding Sites. Biochem Genet 2016;54:211-21. [DOI: 10.1007/s10528-016-9713-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
70 Zhang H, Yi Y, Zhou C, Ying G, Zhou X, Fu C, Zhu Y, Shen Y. SERS detection of microRNA biomarkers for cancer diagnosis using gold-coated paramagnetic nanoparticles to capture SERS-active gold nanoparticles. RSC Adv 2017;7:52782-93. [DOI: 10.1039/c7ra10918k] [Cited by in Crossref: 19] [Article Influence: 4.8] [Reference Citation Analysis]
71 Kunder R, Jalali R, Sridhar E, Moiyadi A, Goel N, Goel A, Gupta T, Krishnatry R, Kannan S, Kurkure P, Deopujari C, Shetty P, Biyani N, Korshunov A, Pfister SM, Northcott PA, Shirsat NV. Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas. Neuro Oncol 2013;15:1644-51. [PMID: 24203893 DOI: 10.1093/neuonc/not123] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
72 Arabkheradmand A, Safari A, Seifoleslami M, Yahaghi E, Gity M. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients. Diagn Pathol 2015;10:178. [PMID: 26415857 DOI: 10.1186/s13000-015-0391-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
73 Wang Y, Lu Z, Fu L, Tan Y, Che D, Huang P, Pi L, Xu Y, Liang Q, Zhang L, Qiu X, Gu X. The miRNA-608 rs4919510 G>C polymorphism confers reduce coronary injury of Kawasaki disease in a Southern Chinese population. Biosci Rep 2019;39:BSR20181660. [PMID: 31043452 DOI: 10.1042/BSR20181660] [Reference Citation Analysis]
74 Singh M, Garg N, Venugopal C, Hallett R, Tokar T, McFarlane N, Mahendram S, Bakhshinyan D, Manoranjan B, Vora P, Qazi M, Arpin CC, Page B, Haftchenary S, Rosa DA, Lai PS, Gómez-Biagi RF, Ali AM, Lewis A, Geletu M, Murty NK, Hassell JA, Jurisica I, Gunning PT, Singh SK. STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation. Oncotarget 2015;6:27461-77. [PMID: 26314961 DOI: 10.18632/oncotarget.4742] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
75 Presneau N, Eskandarpour M, Shemais T, Henderson S, Halai D, Tirabosco R, Flanagan AM. MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. Br J Cancer 2013;108:964-72. [PMID: 23175151 DOI: 10.1038/bjc.2012.518] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
76 Yan H, Wang S, Yu H, Zhu J, Chen C. Molecular pathways and functional analysis of miRNA expression associated with paclitaxel-induced apoptosis in hepatocellular carcinoma cells. Pharmacology 2013;92:167-74. [PMID: 24060847 DOI: 10.1159/000354585] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
77 Li P, Li Q, Zhang Y, Sun S, Liu S, Lu Z. MiR-422a targets MAPKK6 and regulates cell growth and apoptosis in colorectal cancer cells. Biomed Pharmacother 2018;104:832-40. [PMID: 29566993 DOI: 10.1016/j.biopha.2018.03.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
78 Pan Q, Luo X, Chegini N. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J Cell Mol Med 2008;12:227-40. [PMID: 18182067 DOI: 10.1111/j.1582-4934.2007.00207.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 5.6] [Reference Citation Analysis]
79 He Q, Chen Z, Cabay RJ, Zhang L, Luan X, Chen D, Yu T, Wang A, Zhou X. microRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection. Oral Oncol. 2016;57:15-20. [PMID: 27208839 DOI: 10.1016/j.oraloncology.2016.03.017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
80 Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer. 2010;116:41-49. [PMID: 19890957 DOI: 10.1002/cncr.24743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 59] [Article Influence: 0.7] [Reference Citation Analysis]
81 Hui A, How C, Ito E, Liu FF. Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer. 2011;11:500. [PMID: 22128797 DOI: 10.1186/147-2407-11-500] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Han X, Zhang JJ, Han ZQ, Zhang HB, Wang ZA. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB. Cancer Gene Ther 2018;25:300-8. [PMID: 30237418 DOI: 10.1038/s41417-018-0048-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
83 Spizzo R, Nicoloso MS, Calin GA. MicroRNAs as new biomarkers in oncology. Expert Opin Med Diagn 2008;2:115-27. [PMID: 23485132 DOI: 10.1517/17530059.2.2.115] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
84 Vincent A, Van Seuningen I. Epigenetics, stem cells and epithelial cell fate. Differentiation 2009;78:99-107. [PMID: 19632029 DOI: 10.1016/j.diff.2009.07.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
85 Osako Y, Seki N, Kita Y, Yonemori K, Koshizuka K, Kurozumi A, Omoto I, Sasaki K, Uchikado Y, Kurahara H, Maemura K, Natsugoe S. Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma. Int J Oncol. 2016;49:2255-2264. [PMID: 27779648 DOI: 10.3892/ijo.2016.3745] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 8.2] [Reference Citation Analysis]
86 Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM, Li Y, Nelson RA, Mu B, Onami SH. Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One. 2012;7:e35661. [PMID: 22623952 DOI: 10.1371/journal.pone.0035661] [Cited by in Crossref: 123] [Cited by in F6Publishing: 127] [Article Influence: 13.7] [Reference Citation Analysis]
87 Li Z, Li X, Yu C, Wang M, Peng F, Xiao J, Tian R, Jiang J, Sun C. MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3. Tumour Biol. 2014;35:11751-11759. [PMID: 25344675 DOI: 10.1007/s13277- 014-2271-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Yang R, Dick M, Marme F, Schneeweiss A, Langheinz A, Hemminki K, Sutter C, Bugert P, Wappenschmidt B, Varon R, Schott S, Weber BH, Niederacher D, Arnold N, Meindl A, Bartram CR, Schmutzler RK, Müller H, Arndt V, Brenner H, Sohn C, Burwinkel B. Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk. Breast Cancer Res Treat 2011;127:549-54. [PMID: 21046227 DOI: 10.1007/s10549-010-1244-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
89 Da Ros VG, Gutierrez-Perez I, Ferres-Marco D, Dominguez M. Dampening the signals transduced through hedgehog via microRNA miR-7 facilitates notch-induced tumourigenesis. PLoS Biol 2013;11:e1001554. [PMID: 23667323 DOI: 10.1371/journal.pbio.1001554] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
90 Ahmadinejad F, Mowla SJ, Honardoost M, Arjenaki MG, Moazeni-bistgani M, Kheiri S, Teimori H. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis. Tumour Biol 2017;39:101042831769836. [DOI: 10.1177/1010428317698362] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
91 Tomita M. Important Roles of Cellular MicroRNA miR-155 in Leukemogenesis by Human T-Cell Leukemia Virus Type 1 Infection. ISRN Microbiol 2012;2012:978607. [PMID: 23762762 DOI: 10.5402/2012/978607] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
92 Zhang Y, Gao JS, Tang X, Tucker LD, Quesenberry P, Rigoutsos I, Ramratnam B. MicroRNA 125a and its regulation of the p53 tumor suppressor gene. FEBS Lett. 2009;583:3725-3730. [PMID: 19818772 DOI: 10.1016/j.febslet.2009.10.002] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 6.3] [Reference Citation Analysis]
93 Ren Y, Zhang H, Jiang P. MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1. Biol Res 2018;51:51. [PMID: 30474556 DOI: 10.1186/s40659-018-0200-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
94 Xu XL, Jiang YH, Feng JG, Su D, Chen PC, Mao WM. MicroRNA-17, microRNA-18a, and microRNA-19a are prognostic indicators in esophageal squamous cell carcinoma. Ann Thorac Surg 2014;97:1037-45. [PMID: 24360091 DOI: 10.1016/j.athoracsur.2013.10.042] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 7.5] [Reference Citation Analysis]
95 Frasca D, Diaz A, Romero M, Ferracci F, Blomberg BB. MicroRNAs miR-155 and miR-16 Decrease AID and E47 in B Cells from Elderly Individuals. J Immunol 2015;195:2134-40. [PMID: 26223652 DOI: 10.4049/jimmunol.1500520] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
96 Vannucchi AM, Guglielmelli P, Rambaldi A, Bogani C, Barbui T. Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives. J Cell Mol Med 2009;13:1437-50. [PMID: 19522842 DOI: 10.1111/j.1582-4934.2009.00827.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
97 Xu X, Yang X, Xing C, Zhang S, Cao J. miRNA: The nemesis of gastric cancer (Review). Oncol Lett. 2013;6:631-641. [PMID: 24137382 DOI: 10.3892/ol.2013.1428] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
98 Kozaki K, Inazawa J. Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cells. Cancer Sci. 2012;103:837-845. [PMID: 22320679 DOI: 10.1111/j.1349-7006. 2012.02236.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Zarate R, Boni V, Bandres E, Garcia-Foncillas J. MiRNAs and LincRNAs: Could they be considered as biomarkers in colorectal cancer? Int J Mol Sci. 2012;13:840-865. [PMID: 22312290 DOI: 10.3390/ijms13010840] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
100 Cosset E, Petty T, Dutoit V, Tirefort D, Otten-Hernandez P, Farinelli L, Dietrich PY, Preynat-Seauve O. Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness. Biomaterials 2016;107:74-87. [PMID: 27614160 DOI: 10.1016/j.biomaterials.2016.08.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
101 Cao L, Xie B, Yang X, Liang H, Jiang X, Zhang D, Xue P, Chen D, Shao Z. MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1. PLoS One 2015;10:e0133074. [PMID: 26177288 DOI: 10.1371/journal.pone.0133074] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
102 Shea A, Harish V, Afzal Z, Chijioke J, Kedir H, Dusmatova S, Roy A, Ramalinga M, Harris B, Blancato J, Verma M, Kumar D. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Cancer Med 2016;5:1917-46. [PMID: 27282910 DOI: 10.1002/cam4.775] [Cited by in Crossref: 102] [Cited by in F6Publishing: 100] [Article Influence: 20.4] [Reference Citation Analysis]
103 Ding N, Sun X, Wang T, Huang L, Wen J, Zhou Y. miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10. Int J Mol Med 2018;42:381-91. [PMID: 29693138 DOI: 10.3892/ijmm.2018.3639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
104 Robertus J, Harms G, Blokzijl T, Booman M, de Jong D, van Imhoff G, Rosati S, Schuuring E, Kluin P, van den Berg A. Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma. Mod Pathol 2009;22:547-55. [DOI: 10.1038/modpathol.2009.10] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 4.4] [Reference Citation Analysis]
105 Takahashi M, Sung B, Shen Y, Hur K, Link A, Boland CR, Aggarwal BB, Goel A. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family. Carcinogenesis. 2012;33:2441-2449. [PMID: 22983985 DOI: 10.1093/carcin/bgs286] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
106 Zhang B, Yang J, Zou Y, Gong M, Chen H, Hong G, Antaris AL, Li X, Liu C, Chen C, Dai H. Plasmonic micro-beads for fluorescence enhanced, multiplexed protein detection with flow cytometry. Chem Sci 2014;5:4070-5. [DOI: 10.1039/c4sc01206b] [Cited by in Crossref: 29] [Article Influence: 4.1] [Reference Citation Analysis]
107 Bellon M, Lepelletier Y, Hermine O, Nicot C. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 2009;113:4914-7. [PMID: 19246560 DOI: 10.1182/blood-2008-11-189845] [Cited by in Crossref: 105] [Cited by in F6Publishing: 105] [Article Influence: 8.8] [Reference Citation Analysis]
108 Zhang YH, Bai SF, Yan JQ. Blood circulating miRNAs as biomarkers of Alzheimer's disease: a systematic review and meta-analysis. Biomark Med 2019;13:1045-54. [PMID: 31385521 DOI: 10.2217/bmm-2018-0341] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
109 Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res 2010;51:1513-23. [PMID: 20124555 DOI: 10.1194/jlr.M004812] [Cited by in Crossref: 212] [Cited by in F6Publishing: 110] [Article Influence: 19.3] [Reference Citation Analysis]
110 Sondermeijer BM, Bakker A, Halliani A, de Ronde MW, Marquart AA, Tijsen AJ, Mulders TA, Kok MG, Battjes S, Maiwald S, Sivapalaratnam S, Trip MD, Moerland PD, Meijers JC, Creemers EE, Pinto-Sietsma SJ. Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*. PLoS One 2011;6:e25946. [PMID: 22022480 DOI: 10.1371/journal.pone.0025946] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 6.8] [Reference Citation Analysis]
111 Lu L, Liu C, Kang T, Wang X, Guo G, Miao W. In situ enhanced electrochemiluminescence based on co-reactant self-generated for sensitive detection of microRNA. Sensors and Actuators B: Chemical 2018;255:35-41. [DOI: 10.1016/j.snb.2017.08.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
112 Yoshikawa T, Wu J, Otsuka M, Kishikawa T, Ohno M, Shibata C, Takata A, Han F, Kang YJ, Chen CY, Shyu AB, Han J, Koike K. ROCK inhibition enhances microRNA function by promoting deadenylation of targeted mRNAs via increasing PAIP2 expression. Nucleic Acids Res 2015;43:7577-89. [PMID: 26187994 DOI: 10.1093/nar/gkv728] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
113 Wu Q, Yang Z, An Y, Hu H, Yin J, Zhang P, Nie Y, Wu K, Shi Y, Fan D. MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1. Cell Death Dis. 2014;5:e1144. [PMID: 24675462 DOI: 10.1038/cddis.2014.110] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 10.6] [Reference Citation Analysis]
114 Xu L, Zheng Q. Identification and validation of a miRNA-related expression signature for tumor mutational burden in colorectal cancer. World J Surg Oncol 2021;19:56. [PMID: 33610190 DOI: 10.1186/s12957-021-02137-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
115 Li J, Liang H, Bai M, Ning T, Wang C, Fan Q, Wang Y, Fu Z, Wang N, Liu R, Zen K, Zhang CY, Chen X, Ba Y. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer. PLoS One 2015;10:e0130194. [PMID: 26061281 DOI: 10.1371/journal.pone.0130194] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
116 Carloni G, Fioretti D, Rinaldi M, Ponzetto A. Heterogeneity and coexistence of oncogenic mechanisms involved in HCV-associated B-cell lymphomas. Crit Rev Oncol Hematol 2019;138:156-71. [PMID: 31092372 DOI: 10.1016/j.critrevonc.2019.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
117 Nishimura M, Jung EJ, Shah MY, Lu C, Spizzo R, Shimizu M, Han HD, Ivan C, Rossi S, Zhang X. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discov. 2013;3:1302-1315. [PMID: 24002999 DOI: 10.1158/2159-8290.cd-13-0159] [Cited by in Crossref: 103] [Cited by in F6Publishing: 60] [Article Influence: 12.9] [Reference Citation Analysis]
118 Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV, Prystowsky MB, Belbin TJ, Schlecht NF. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 2009;174:736-45. [PMID: 19179615 DOI: 10.2353/ajpath.2009.080731] [Cited by in Crossref: 251] [Cited by in F6Publishing: 233] [Article Influence: 20.9] [Reference Citation Analysis]
119 Ma C, Zheng C, Bai E, Yang K. miR-101 inhibits glioma cell invasion via the downregulation of COX-2. Oncol Lett 2016;12:2538-44. [PMID: 27698824 DOI: 10.3892/ol.2016.4939] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
120 Moore LM, Kivinen V, Liu Y, Annala M, Cogdell D, Liu X, Liu CG, Sawaya R, Yli-Harja O, Shmulevich I, Fuller GN, Zhang W, Nykter M. Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma. J Pathol 2013;229:449-59. [PMID: 23007860 DOI: 10.1002/path.4109] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
121 Chen L, Jin H. MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies. Tumor Biol 2014;35:9119-29. [DOI: 10.1007/s13277-014-2188-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
122 Xu QL, Luo Z, Zhang B, Qin GJ, Zhang RY, Kong XY, Tang HY, Jiang W. Methylation-associated silencing of miR-9-1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2. Cancer Sci 2021. [PMID: 34382305 DOI: 10.1111/cas.15103] [Reference Citation Analysis]
123 Urdinez J, Boro A, Mazumdar A, Arlt MJ, Muff R, Botter SM, Bode-Lesniewska B, Fuchs B, Snedeker JG, Gvozdenovic A. The miR-143/145 Cluster, a Novel Diagnostic Biomarker in Chondrosarcoma, Acts as a Tumor Suppressor and Directly Inhibits Fascin-1. J Bone Miner Res 2020;35:1077-91. [PMID: 32027760 DOI: 10.1002/jbmr.3976] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
124 Gupta P, Cairns MJ, Saksena NK. Regulation of gene expression by microRNA in HCV infection and HCV-mediated hepatocellular carcinoma. Virol J. 2014;11:64. [PMID: 24690114 DOI: 10.1186/1743-422x-11-64] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
125 Ma Z, Gu G, Pan W, Chen X. LncRNA PCAT6 Accelerates the Progression and Chemoresistance of Cervical Cancer Through Up-Regulating ZEB1 by Sponging miR-543. Onco Targets Ther 2020;13:1159-70. [PMID: 32103984 DOI: 10.2147/OTT.S232354] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]
126 Mohapatra S, Pioppini C, Ozpolat B, Calin GA. Non-coding RNAs regulation of macrophage polarization in cancer. Mol Cancer 2021;20:24. [PMID: 33522932 DOI: 10.1186/s12943-021-01313-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
127 Kundu ST, Byers LA, Peng DH, Roybal JD, Diao L, Wang J, Tong P, Creighton CJ, Gibbons DL. The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers. Oncogene 2016;35:173-86. [PMID: 25798833 DOI: 10.1038/onc.2015.71] [Cited by in Crossref: 70] [Cited by in F6Publishing: 78] [Article Influence: 11.7] [Reference Citation Analysis]
128 Van Goethem A, Yigit N, Everaert C, Moreno-Smith M, Mus LM, Barbieri E, Speleman F, Mestdagh P, Shohet J, Van Maerken T, Vandesompele J. Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples. Sci Rep 2016;6:37876. [PMID: 27901112 DOI: 10.1038/srep37876] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
129 Ren Y, Li X, Wang W, He W, Wang J, Wang Y. Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma Patients. Clin Lymphoma Myeloma Leuk 2017;17:415-23. [PMID: 28601493 DOI: 10.1016/j.clml.2017.05.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
130 Gerson KD, Maddula VS, Seligmann BE, Shearstone JR, Khan A, Mercurio AM. Effects of β4 integrin expression on microRNA patterns in breast cancer. Biol Open 2012;1:658-66. [PMID: 23213459 DOI: 10.1242/bio.20121628] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
131 Yan H, Choi AJ, Lee BH, Ting AH. Identification and functional analysis of epigenetically silenced microRNAs in colorectal cancer cells. PLoS One. 2011;6:e20628. [PMID: 21698188 DOI: 10.1371/journal.pone.0020628] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
132 Tsai MM, Wang CS, Tsai CY, Huang CG, Lee KF, Huang HW, Lin YH, Chi HC, Kuo LM, Lu PH, Lin KH. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer. Eur J Cancer. 2016;64:137-148. [PMID: 27420607 DOI: 10.1016/j.ejca.2016.05.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
133 Wang TZ, Lin DD, Jin BX, Sun XY, Li N. Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging. Exp Ther Med. 2019;17:1919-1929. [PMID: 30783469 DOI: 10.3892/etm.2018.7117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
134 Diamantopoulos MA, Tsiakanikas P, Scorilas A. Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer. Ann Transl Med 2018;6:241. [PMID: 30069443 DOI: 10.21037/atm.2018.06.10] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 16.0] [Reference Citation Analysis]
135 Frankel A. Formalin fixation in the '-omics' era: a primer for the surgeon-scientist. ANZ J Surg 2012;82:395-402. [PMID: 22571596 DOI: 10.1111/j.1445-2197.2012.06092.x] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
136 Jin Y, Wang J, Han J, Luo D, Sun Z. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway. Exp Cell Res 2017;360:210-7. [PMID: 28890291 DOI: 10.1016/j.yexcr.2017.09.010] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 13.5] [Reference Citation Analysis]
137 Waldman SA, Terzic A. Applications of microRNA in cancer: Exploring the advantages of miRNA. Clin Transl Sci 2009;2:248-9. [PMID: 20443899 DOI: 10.1111/j.1752-8062.2009.00110.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
138 Ghosh R, Singh LC, Shohet JM, Gunaratne PH. A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells. Biomaterials. 2013;34:807-816. [PMID: 23111335 DOI: 10.1016/j.biomaterials.2012.10.023] [Cited by in Crossref: 101] [Cited by in F6Publishing: 93] [Article Influence: 11.2] [Reference Citation Analysis]
139 Ma B, Liu F, Zhang S, Duan J, Kong Y, Li Z, Tang D, Wang W, Ge S, Tang W, Liu H. Two-photon fluorescent polydopamine nanodots for CAR-T cell function verification and tumor cell/tissue detection. J Mater Chem B 2018;6:6459-67. [PMID: 32254653 DOI: 10.1039/c8tb01930d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.7] [Reference Citation Analysis]
140 He Y, Yang Y, Kuang P, Ren S, Rozeboom L, Rivard CJ, Li X, Zhou C, Hirsch FR. Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules. Onco Targets Ther 2017;10:5915-26. [PMID: 29263681 DOI: 10.2147/OTT.S151432] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
141 Ma X, Yoshimoto K, Guan Y, Hata N, Mizoguchi M, Sagata N, Murata H, Kuga D, Amano T, Nakamizo A, Sasaki T. Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma. Neuro Oncol 2012;14:1153-62. [PMID: 22844109 DOI: 10.1093/neuonc/nos145] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
142 Liu T, Li P, Li J, Qi Q, Sun Z, Shi S, Xie Y, Liu S, Wang Y, Du L, Wang C. Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma. Mol Ther Oncolytics 2021;23:163-80. [PMID: 34729394 DOI: 10.1016/j.omto.2021.09.003] [Reference Citation Analysis]
143 Akhtar MM, Micolucci L, Islam MS, Olivieri F, Procopio AD. Bioinformatic tools for microRNA dissection. Nucleic Acids Res 2016;44:24-44. [PMID: 26578605 DOI: 10.1093/nar/gkv1221] [Cited by in Crossref: 123] [Cited by in F6Publishing: 106] [Article Influence: 20.5] [Reference Citation Analysis]
144 Garg M. MicroRNAs, stem cells and cancer stem cells. World J Stem Cells 2012; 4(7): 62-70 [PMID: 22993663 DOI: 10.4252/wjsc.v4.i7.62] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
145 Ren D, Lin B, Zhang X, Peng Y, Ye Z, Ma Y, Liang Y, Cao L, Li X, Li R, Sun L, Liu Q, Wu J, Zhou K, Zeng J. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway. Oncotarget. 2017;8:49807-49823. [PMID: 28591704 DOI: 10.18632/oncotarget.17971] [Cited by in Crossref: 79] [Cited by in F6Publishing: 93] [Article Influence: 26.3] [Reference Citation Analysis]
146 Chen S, Lao J, Geng Q, Zhang J, Wu A, Xu D. A 3-MicroRNA Signature Identified From Serum Predicts Clinical Outcome of the Locally Advanced Gastric Cancer. Front Oncol 2020;10:565. [PMID: 32656071 DOI: 10.3389/fonc.2020.00565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Iliopoulos D, Kavousanaki M, Ioannou M, Boumpas D, Verginis P. The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21. Eur J Immunol 2011;41:1754-63. [PMID: 21469086 DOI: 10.1002/eji.201040646] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
148 Chen Z, Liu X, Hu Z, Wang Y, Liu M, Liu X, Li H, Ji R, Guo Q, Zhou Y. Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. Oncol Lett 2015;10:329-36. [PMID: 26171025 DOI: 10.3892/ol.2015.3179] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
149 Mei LL, Wang WJ, Qiu YT, Xie XF, Bai J, Shi ZZ. miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma. PLoS One 2017;12:e0185636. [PMID: 28968424 DOI: 10.1371/journal.pone.0185636] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
150 Jia W, Wu Y, Zhang Q, Gao GE, Zhang C, Xiang Y. Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring. Mol Clin Oncol 2015;3:851-8. [PMID: 26171195 DOI: 10.3892/mco.2015.560] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
151 Yumrutas O, Kara M, Atilgan R, Kavak SB, Bozgeyik I, Sapmaz E. Application of talcum powder, trichloroacetic acid and silver nitrate in female rats for non-surgical sterilization: evaluation of the apoptotic pathway mRNA and miRNA genes. Int J Exp Pathol 2015;96:111-5. [PMID: 25885949 DOI: 10.1111/iep.12123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
152 Huang J, Wang X, Wen G, Ren Y. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells. Oncol Rep 2019;42:1677-88. [PMID: 31545453 DOI: 10.3892/or.2019.7307] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
153 Benetatos L, Vartholomatos G. Deregulated microRNAs in multiple myeloma. Cancer. 2012;118:878-887. [PMID: 21837684 DOI: 10.1002/cncr.26297] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
154 Wang ZX, Deng TX, Ma Z. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma. J Cell Biochem. 2019;120:16416-16426. [PMID: 31297864 DOI: 10.1002/jcb.28601] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
155 Megiorni F, Cialfi S, McDowell HP, Felsani A, Camero S, Guffanti A, Pizer B, Clerico A, De Grazia A, Pizzuti A, Moles A, Dominici C. Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members. BMC Cancer 2014;14:880. [PMID: 25427715 DOI: 10.1186/1471-2407-14-880] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
156 Gilmour J, Lavender P. Control of IL-4 expression in T helper 1 and 2 cells. Immunology 2008;124:437-44. [PMID: 18479352 DOI: 10.1111/j.1365-2567.2008.02845.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
157 Shi W, Yang J, Li S, Shan X, Liu X, Hua H, Zhao C, Feng Z, Cai Z, Zhang L, Zhou D. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5. Oncotarget 2015;6:40172-85. [PMID: 26474386 DOI: 10.18632/oncotarget.5502] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
158 Li C, Hu Q, Chen Z, Shen B, Yang J, Kang P, Zhou Z, Pei F. MicroRNA-140 Suppresses Human Chondrocytes Hypertrophy by Targeting SMAD1 and Controlling the Bone Morphogenetic Protein Pathway in Osteoarthritis. The American Journal of the Medical Sciences 2018;355:477-87. [DOI: 10.1016/j.amjms.2018.01.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
159 Yoshioka Y, Kosaka N, Ochiya T, Kato T. Micromanaging Iron Homeostasis: hypoxia-inducible micro-RNA-210 suppresses iron homeostasis-related proteins. J Biol Chem 2012;287:34110-9. [PMID: 22896707 DOI: 10.1074/jbc.M112.356717] [Cited by in Crossref: 51] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
160 Chen X, Jiang Z, Xie D, Huang D, Zhao Q, Yan G, You Z. A novel computational model based on super-disease and miRNA for potential miRNA–disease association prediction. Mol BioSyst 2017;13:1202-12. [DOI: 10.1039/c6mb00853d] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
161 Dong X, Li Y, Cao R, Xu H. MicroRNA-363-3p Inhibits the Expression of Renal Fibrosis Markers in TGF-β1-Treated HK-2 Cells by Targeting TGF-β2. Biochem Genet 2021;59:1033-48. [PMID: 33630202 DOI: 10.1007/s10528-021-10044-z] [Reference Citation Analysis]
162 Lu GF, You CY, Chen YS, Jiang H, Zheng X, Tang WW, Wang XY, Xu HY, Geng F. MicroRNA-671-3p promotes proliferation and migration of glioma cells via targeting CKAP4. Onco Targets Ther 2018;11:6217-26. [PMID: 30288057 DOI: 10.2147/OTT.S177325] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
163 Csermely P, Korcsmáros T, Kiss HJ, London G, Nussinov R. Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther 2013;138:333-408. [PMID: 23384594 DOI: 10.1016/j.pharmthera.2013.01.016] [Cited by in Crossref: 544] [Cited by in F6Publishing: 401] [Article Influence: 68.0] [Reference Citation Analysis]
164 Breving K, Esquela-Kerscher A. The complexities of microRNA regulation: mirandering around the rules. Int J Biochem Cell Biol. 2010;42:1316-1329. [PMID: 19800023 DOI: 10.1016/j.biocel.2009.09.016] [Cited by in Crossref: 145] [Cited by in F6Publishing: 149] [Article Influence: 12.1] [Reference Citation Analysis]
165 Li H, Jin X, Chen B, Li P, Li Q. Autophagy-regulating microRNAs: potential targets for improving radiotherapy. J Cancer Res Clin Oncol 2018;144:1623-34. [PMID: 29971533 DOI: 10.1007/s00432-018-2675-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
166 Fang S, Gao M, Xiong S, Chen Q, Zhang H. Expression of serum Hsa-miR-93 in uterine cancer and its clinical significance. Oncol Lett 2018;15:9896-900. [PMID: 29844841 DOI: 10.3892/ol.2018.8553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
167 Palomino-vizcaino G, Alvarez-salas LM. Therapeutic Oligonucleotides Against Cancer: Recent Approaches and New Perspectives. Nucleic Acid Nanotheranostics. Elsevier; 2019. pp. 1-26. [DOI: 10.1016/b978-0-12-814470-1.00001-0] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
168 Liu H, Pan Y, Han X, Liu J, Li R. MicroRNA-216a promotes the metastasis and epithelial-mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway. Onco Targets Ther 2017;10:2701-9. [PMID: 28579808 DOI: 10.2147/OTT.S114318] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
169 Wu H, Wei Y, Pan S. Down‐regulation and clinical significance of miR‐7‐2‐3p in papillary thyroid carcinoma with multiple detecting methods. IET syst biol 2019;13:225-33. [DOI: 10.1049/iet-syb.2019.0025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
170 Shu Y, Pi F, Sharma A, Rajabi M, Haque F, Shu D, Leggas M, Evers BM, Guo P. Stable RNA nanoparticles as potential new generation drugs for cancer therapy. Adv Drug Deliv Rev. 2014;66:74-89. [PMID: 24270010 DOI: 10.1016/j.addr.2013.11.006] [Cited by in Crossref: 148] [Cited by in F6Publishing: 141] [Article Influence: 18.5] [Reference Citation Analysis]
171 Li Q, Liu Q. Noncoding RNAs in Cancer Immunology. Adv Exp Med Biol 2016;927:243-64. [PMID: 27376738 DOI: 10.1007/978-981-10-1498-7_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
172 Yu Z, Xu Z, Disante G, Wright J, Wang M, Li Y, Zhao Q, Ren T, Ju X, Gutman E, Wang G, Addya S, Li T, Xiang Z, Wang C, Yang X, Yang X, Pestell R. miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1. Oncotarget 2014;5:1083-90. [PMID: 24658544 DOI: 10.18632/oncotarget.1804] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
173 Togliatto G, Trombetta A, Dentelli P, Rosso A, Brizzi MF. MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage. Diabetologia. 2011;54:1930-1940. [PMID: 21461636 DOI: 10.1007/s00125-011-2125 -5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
174 Li M, Wu F, Ji Y, Yang L, Li F. Meta-analysis of microRNAs as potential biomarkers for detecting esophageal carcinoma in Asian populations. Int J Biol Markers. 2017;32:e375-e383. [PMID: 28862713 DOI: 10.5301/ijbm.5000296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
175 Murugan AK, Munirajan AK, Alzahrani AS. MicroRNAs: Modulators of the Ras Oncogenes in Oral Cancer: miRNAs AND RAS ONCOGENES IN ORAL CANCER. J Cell Physiol 2016;231:1424-31. [DOI: 10.1002/jcp.25269] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
176 Moens U. Silencing viral microRNA as a novel antiviral therapy? J Biomed Biotechnol 2009;2009:419539. [PMID: 19704916 DOI: 10.1155/2009/419539] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
177 Wang J, Xu Y, Wang J, Ying H. Circulating miR-214-3p predicts nasopharyngeal carcinoma recurrence or metastasis. Clin Chim Acta 2020;503:54-60. [PMID: 31926154 DOI: 10.1016/j.cca.2020.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
178 Bao Y, Chen B, Wu Q, Hu K, Xi X, Zhu W, Zhong X, Chen J. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7. Clin Exp Med 2017;17:51-8. [PMID: 26515813 DOI: 10.1007/s10238-015-0398-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
179 Yin J, Zhao J, Hu W, Yang G, Yu H, Wang R, Wang L, Zhang G, Fu W, Dai L, Li W, Liao B, Zhang S. Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer. PLoS One 2017;12:e0172787. [PMID: 28235063 DOI: 10.1371/journal.pone.0172787] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
180 Calura E, Bisognin A, Manzoni M, Todoerti K, Taiana E, Sales G, Morgan GJ, Tonon G, Amodio N, Tassone P, Neri A, Agnelli L, Romualdi C, Bortoluzzi S. Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients. Oncotarget 2016;7:2367-78. [PMID: 26496024 DOI: 10.18632/oncotarget.6151] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
181 Wang Q, Li P, Li A, Jiang W, Wang H, Wang J, Xie K. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma. J Exp Clin Cancer Res 2012;31:97. [PMID: 23174013 DOI: 10.1186/1756-9966-31-97] [Cited by in Crossref: 108] [Cited by in F6Publishing: 111] [Article Influence: 12.0] [Reference Citation Analysis]
182 Nouraee N, Mowla SJ, Calin GA. Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy. Genes Chromosomes Cancer 2015;54:335-52. [PMID: 25832733 DOI: 10.1002/gcc.22244] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
183 Thapar R. Regulation of DNA Double-Strand Break Repair by Non-Coding RNAs. Molecules 2018;23:E2789. [PMID: 30373256 DOI: 10.3390/molecules23112789] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 12.7] [Reference Citation Analysis]
184 Zhang L, Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zhao XM. A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma. Oncotarget 2016;7:3587-98. [PMID: 26657296 DOI: 10.18632/oncotarget.6534] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
185 De Cicco P, Ercolano G, Ianaro A. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion. Front Immunol 2020;11:1680. [PMID: 32849585 DOI: 10.3389/fimmu.2020.01680] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 26.0] [Reference Citation Analysis]
186 Croce C. Introduction to the role of microRNAs in cancer diagnosis, prognosis, and treatment. Cancer J 2012;18:213-4. [PMID: 22647356 DOI: 10.1097/PPO.0b013e31825efb41] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
187 Chafin CB, Reilly CM. MicroRNAs implicated in the immunopathogenesis of lupus nephritis. Clin Dev Immunol 2013;2013:430239. [PMID: 23983769 DOI: 10.1155/2013/430239] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
188 Ye F, Tang H, Liu Q, Xie X, Wu M, Liu X, Chen B, Xie X. miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family. J Transl Med 2014;12:17. [PMID: 24447584 DOI: 10.1186/1479-5876-12-17] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
189 Shen Q, Bae HJ, Eun JW, Kim HS, Park SJ, Shin WC, Lee EK, Park S, Park WS, Lee JY, Nam SW. MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer. Cancer Lett 2014;344:204-11. [PMID: 24189458 DOI: 10.1016/j.canlet.2013.10.030] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
190 Ruebel K, Leontovich AA, Stilling GA, Zhang S, Righi A, Jin L, Lloyd RV. MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression. Mod Pathol. 2010;23:367-375. [PMID: 20037573 DOI: 10.1038/modpathol.2009.161] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 5.8] [Reference Citation Analysis]
191 Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA. 2008;105:7004-7009. [PMID: 18458333 DOI: 10.1073/pnas.0801615105] [Cited by in Crossref: 365] [Cited by in F6Publishing: 373] [Article Influence: 28.1] [Reference Citation Analysis]
192 Liu S, Su W, Li Z, Ding X. Electrochemical detection of lung cancer specific microRNAs using 3D DNA origami nanostructures. Biosensors and Bioelectronics 2015;71:57-61. [DOI: 10.1016/j.bios.2015.04.006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 11.7] [Reference Citation Analysis]
193 Pourbagheri-Sigaroodi A, Bashash D, Safaroghli-Azar A, Farshi-Paraasghari M, Momeny M, Mansoor FN, Ghaffari SH. Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line. Eur J Pharmacol 2019;846:49-62. [PMID: 30658112 DOI: 10.1016/j.ejphar.2019.01.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
194 Jang JY, Kim YS, Kang KN, Kim KH, Park YJ, Kim CW. Multiple microRNAs as biomarkers for early breast cancer diagnosis. Mol Clin Oncol 2021;14:31. [PMID: 33414912 DOI: 10.3892/mco.2020.2193] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
195 Liu Z, Gersbach E, Zhang X, Xu X, Dong R, Lee P, Liu J, Kong B, Shao C, Wei JJ. miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma. Mol Cancer Res. 2013;11:1314-1325. [PMID: 24045973 DOI: 10.1158/1541-7786.MCR-13-0131] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
196 Guessous F, Zhang Y, Kofman A, Catania A, Li Y, Schiff D, Purow B, Abounader R. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle. 2010;9:1031-1036. [PMID: 20190569 DOI: 10.4161/cc.9.6.10987] [Cited by in Crossref: 212] [Cited by in F6Publishing: 195] [Article Influence: 19.3] [Reference Citation Analysis]
197 Adams SV, Newcomb PA, Burnett-Hartman AN, Wurscher MA, Mandelson M, Upton MP, Zhu LC, Potter JD, Makar KW. Rare circulating microRNAs as biomarkers of colorectal neoplasia. PLoS One. 2014;9:e108668. [PMID: 25286412 DOI: 10.1371/journal.pone.0108668] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
198 Asadzadeh-firouzabadi A, Zare HR. Preparation and application of AgNPs/SWCNTs nanohybrid as an electroactive label for sensitive detection of miRNA related to lung cancer. Sensors and Actuators B: Chemical 2018;260:824-31. [DOI: 10.1016/j.snb.2017.12.195] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
199 Lee NH, Kim SJ, Hyun J. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer. Biomedicines 2021;9:347. [PMID: 33808155 DOI: 10.3390/biomedicines9040347] [Reference Citation Analysis]
200 Hu S, Jiang Q, Luo D, Zhao L, Fu X, Chen Y, Song X, Li L, Zhao H, He Y, Peng B. miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma. Oncotarget 2016;7:48423-31. [PMID: 27374173 DOI: 10.18632/oncotarget.10301] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
201 Salinas-Vera YM, Gallardo-Rincón D, García-Vázquez R, Hernández-de la Cruz ON, Marchat LA, González-Barrios JA, Ruíz-García E, Vázquez-Calzada C, Contreras-Sanzón E, Resendiz-Hernández M, Astudillo-de la Vega H, Cruz-Colin JL, Campos-Parra AD, López-Camarillo C. HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells. Front Oncol 2019;9:381. [PMID: 31157166 DOI: 10.3389/fonc.2019.00381] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
202 Iorio MV, Croce CM. microRNA involvement in human cancer. Carcinogenesis 2012;33:1126-33. [PMID: 22491715 DOI: 10.1093/carcin/bgs140] [Cited by in Crossref: 375] [Cited by in F6Publishing: 371] [Article Influence: 41.7] [Reference Citation Analysis]
203 Hisaoka M, Matsuyama A, Nagao Y, Luan L, Kuroda T, Akiyama H, Kondo S, Hashimoto H. Identification of altered MicroRNA expression patterns in synovial sarcoma. Genes Chromosomes Cancer 2011;50:137-45. [PMID: 21213367 DOI: 10.1002/gcc.20837] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
204 Bi S, Zhang J, Hao S, Ding C, Zhang S. Exponential Amplification for Chemiluminescence Resonance Energy Transfer Detection of MicroRNA in Real Samples Based on a Cross-Catalyst Strand-Displacement Network. Anal Chem 2011;83:3696-702. [DOI: 10.1021/ac200096b] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 7.5] [Reference Citation Analysis]
205 Manfè V, Biskup E, Rosbjerg A, Kamstrup M, Skov AG, Lerche CM, Lauenborg BT, Odum N, Gniadecki R. miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. PLoS One 2012;7:e29541. [PMID: 22235305 DOI: 10.1371/journal.pone.0029541] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 8.1] [Reference Citation Analysis]
206 Wang Y, Wang Y, Yang GY. MicroRNAs in Cerebral Ischemia. Stroke Res Treat 2013;2013:276540. [PMID: 23533957 DOI: 10.1155/2013/276540] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
207 Yu C, Qian L, Uttamchandani M, Li L, Yao SQ. Single-Vehicular Delivery of Antagomir and Small Molecules to Inhibit miR-122 Function in Hepatocellular Carcinoma Cells by using “Smart” Mesoporous Silica Nanoparticles. Angew Chem 2015;127:10720-4. [DOI: 10.1002/ange.201504913] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
208 Chen W, Tong K, Yu J. MicroRNA-130a is upregulated in colorectal cancer and promotes cell growth and motility by directly targeting forkhead box F2. Mol Med Rep 2017;16:5241-8. [PMID: 28849155 DOI: 10.3892/mmr.2017.7257] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
209 Si W, Shen J, Zheng H, Fan W. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics. 2019;11:25. [PMID: 30744689 DOI: 10.1186/s13148-018-0587-8] [Cited by in Crossref: 146] [Cited by in F6Publishing: 149] [Article Influence: 73.0] [Reference Citation Analysis]
210 Banerjee P, Crawford L, Samuelson E, Feuer G. Hematopoietic stem cells and retroviral infection. Retrovirology 2010;7:8. [PMID: 20132553 DOI: 10.1186/1742-4690-7-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
211 Summerer I, Hess J, Pitea A, Unger K, Hieber L, Selmansberger M, Lauber K, Zitzelsberger H. Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells. BMC Genomics 2015;16:654. [PMID: 26328888 DOI: 10.1186/s12864-015-1865-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
212 Maleki S, Jabalee J, Garnis C. The Role of Extracellular Vesicles in Mediating Resistance to Anticancer Therapies. Int J Mol Sci 2021;22:4166. [PMID: 33920605 DOI: 10.3390/ijms22084166] [Reference Citation Analysis]
213 Zhao X, Liu K, Zhu G, He F, Duval B, Richer J, Huang D, Jiang C, Hao J, Chen L. Identifying cancer-related microRNAs based on gene expression data. Bioinformatics 2015;31:1226-34. [DOI: 10.1093/bioinformatics/btu811] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 8.1] [Reference Citation Analysis]
214 Hoon DS, Ferris R, Tanaka R, Chong KK, Alix-Panabières C, Pantel K. Molecular mechanisms of metastasis. J Surg Oncol. 2011;103:508-517. [PMID: 21480243 DOI: 10.1002/jso.21690] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
215 Yu H, Chen Y, Jiang P. Circular RNA HIPK3 exerts oncogenic properties through suppression of miR-124 in lung cancer. Biochem Biophys Res Commun 2018;506:455-62. [PMID: 30352682 DOI: 10.1016/j.bbrc.2018.10.087] [Cited by in Crossref: 51] [Cited by in F6Publishing: 60] [Article Influence: 17.0] [Reference Citation Analysis]
216 Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M. Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis. 2012;33:2391-2397. [PMID: 22983984 DOI: 10.1093/carcin/bgs288] [Cited by in Crossref: 121] [Cited by in F6Publishing: 123] [Article Influence: 13.4] [Reference Citation Analysis]
217 He XX, Kuang SZ, Liao JZ, Xu CR, Chang Y, Wu YL, Gong J, Tian DA, Guo AY, Lin JS. The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma. Mol Biosyst 2015;11:532-9. [PMID: 25424171 DOI: 10.1039/c4mb00563e] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 7.3] [Reference Citation Analysis]
218 Summerer I, Niyazi M, Unger K, Pitea A, Zangen V, Hess J, Atkinson MJ, Belka C, Moertl S, Zitzelsberger H. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Radiat Oncol 2013;8:296. [PMID: 24373621 DOI: 10.1186/1748-717X-8-296] [Cited by in Crossref: 66] [Cited by in F6Publishing: 41] [Article Influence: 8.3] [Reference Citation Analysis]
219 Wang F, Hou J, Jin W, Li J, Yue Y, Jin H, Wang X. Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: a meta-analysis. Molecules 2014;19:6282-93. [PMID: 24840899 DOI: 10.3390/molecules19056282] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
220 Jiang X, Wang H, Chai Y, Li H, Shi W, Yuan R. DNA Cascade Reaction with High-Efficiency Target Conversion for Ultrasensitive Electrochemiluminescence microRNA Detection. Anal Chem 2019;91:10258-65. [DOI: 10.1021/acs.analchem.9b02404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
221 Liao R, Li S, Wang H, Chen C, Chen X, Cai C. Simultaneous detection of two hepatocellar carcinoma-related microRNAs using a clever single-labeled fluorescent probe. Analytica Chimica Acta 2017;983:181-8. [DOI: 10.1016/j.aca.2017.06.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
222 Valastyan S. RETRACTED ARTICLE: Roles of MicroRNAs and Other Non-coding RNAs in Breast Cancer Metastasis. J Mammary Gland Biol Neoplasia 2012;17:23-32. [DOI: 10.1007/s10911-012-9241-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
223 Jeong B, Kim YJ, Jeong J, Kim YJ. Label-free electrochemical quantification of microRNA-375 in prostate cancer cells. Journal of Electroanalytical Chemistry 2019;846:113127. [DOI: 10.1016/j.jelechem.2019.05.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
224 Markou A, Liang Y, Lianidou E. Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. Clin Chem Lab Med 2011;49:1591-603. [PMID: 21767219 DOI: 10.1515/CCLM.2011.661] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
225 Valleron W, Ysebaert L, Berquet L, Fataccioli V, Quelen C, Martin A, Parrens M, Lamant L, de Leval L, Gisselbrecht C. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. Blood. 2012;120:3997-4005. [PMID: 22990019 DOI: 10.1182/blood-2012-06-438135] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
226 Niu YW, Wang GH, Yan GY, Chen X. Integrating random walk and binary regression to identify novel miRNA-disease association. BMC Bioinformatics 2019;20:59. [PMID: 30691413 DOI: 10.1186/s12859-019-2640-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
227 Piatopoulou D, Avgeris M, Marmarinos A, Xagorari M, Baka M, Doganis D, Kossiva L, Scorilas A, Gourgiotis D. miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment. Br J Cancer. 2017;117:801-812. [PMID: 28787435 DOI: 10.1038/bjc.2017.256] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
228 Huang J, Liang Y, Xu M, Xiong J, Wang D, Ding Q. MicroRNA-124 acts as a tumor-suppressive miRNA by inhibiting the expression of Snail2 in osteosarcoma. Oncol Lett 2018;15:4979-87. [PMID: 29552134 DOI: 10.3892/ol.2018.7994] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
229 Berger F, Reiser MF. Micro-RNAs as potential new molecular biomarkers in oncology: have they reached relevance for the clinical imaging sciences? Theranostics. 2013;3:943-952. [PMID: 24396505 DOI: 10.7150/thno.7445] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
230 Li Q, Ding C, Chen C, Zhang Z, Xiao H, Xie F, Lei L, Chen Y, Mao B, Jiang M. miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma. J Gastroenterol Hepatol. 2014;29:835-842. [PMID: 24219032 DOI: 10.1111/jgh.12429] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 8.6] [Reference Citation Analysis]
231 Dai Y, Zhang X. MicroRNA Delivery with Bioreducible Polyethylenimine as a Non‐Viral Vector for Breast Cancer Gene Therapy. Macromol Biosci 2019;19:1800445. [DOI: 10.1002/mabi.201800445] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
232 Luo L, Yang F, Ding J, Yan D, Wang D, Yang S, Ding L, Li J, Chen D, Ma R, Wu J, Tang J. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer. Gene 2016;594:47-58. [DOI: 10.1016/j.gene.2016.08.057] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
233 Pandyarajan V, Govalan R, Yang JD. Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma. Int J Mol Sci 2021;22:E479. [PMID: 33418899 DOI: 10.3390/ijms22020479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
234 Chen J, Jiang Y, Zhou J, Liu S, Qin N, Du J, Jin G, Hu Z, Ma H, Shen H, Dai J. Evaluation of CpG-SNPs in miRNA promoters and risk of breast cancer. Gene 2018;651:1-8. [PMID: 29374520 DOI: 10.1016/j.gene.2018.01.070] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
235 Nwaneri AC, Mcbeth L, Hinds TD. Prostate Cancer in African American Men: The Effect of Androgens and microRNAs on Epidermal Growth Factor Signaling. HORM CANC 2016;7:296-304. [DOI: 10.1007/s12672-016-0271-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
236 Rybicka A, Król M. Identification and characterization of cancer stem cells in canine mammary tumors. Acta Vet Scand 2016;58:86. [PMID: 27993142 DOI: 10.1186/s13028-016-0268-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
237 Qin Y, Chen W, Liu B, Zhou L, Deng L, Niu W, Bao D, Cheng C, Li D, Liu S, Niu C. MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin. Theranostics 2017;7:1663-73. [PMID: 28529643 DOI: 10.7150/thno.17886] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
238 Xu YF, Mao YP, Li YQ, Ren XY, He QM, Tang XR, Sun Y, Liu N, Ma J. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2. Cancer Lett 2015;363:146-55. [PMID: 25892549 DOI: 10.1016/j.canlet.2015.04.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
239 Verderio P, Bottelli S, Lecchi M, Plebani M, Gariboldi M, Pizzamiglio S, Ciniselli CM. Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'-Methodological challenges in combining miRNAs as circulating biomarkers. Br J Cancer 2016;114:e5. [PMID: 27100729 DOI: 10.1038/bjc.2016.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
240 Reynolds MA. Molecular alterations in prostate cancer. Cancer Lett 2008;271:13-24. [PMID: 18554779 DOI: 10.1016/j.canlet.2008.04.047] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
241 Xiao J, Li Y, Zhang W, Jiang Y, Du B, Tan Y. miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22. Onco Targets Ther 2016;9:1525-34. [PMID: 27051294 DOI: 10.2147/OTT.S98378] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
242 De Mariano M, Stigliani S, Moretti S, Parodi F, Croce M, Bernardi C, Pagano A, Tonini GP, Ferrini S, Longo L. A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma. Oncotarget 2017;8:56518-32. [PMID: 28915608 DOI: 10.18632/oncotarget.17033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
243 Chen R, Liao JY, Huang J, Chen WL, Ma XJ, Luo XD. [ARTICLE WITHDRAWN] Downregulation of SRC Kinase Signaling Inhibitor 1 (SRCIN1) Expression by MicroRNA-32 Promotes Proliferation and Epithelial-Mesenchymal Transition in Human Liver Cancer Cells. Oncol Res 2018;26:573-9. [PMID: 28550679 DOI: 10.3727/096504017X14954923820137] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
244 Quintavalle C, Mangani D, Roscigno G, Romano G, Diaz-Lagares A, Iaboni M, Donnarumma E, Fiore D, De Marinis P, Soini Y, Esteller M, Condorelli G. MiR-221/222 target the DNA methyltransferase MGMT in glioma cells. PLoS One 2013;8:e74466. [PMID: 24147153 DOI: 10.1371/journal.pone.0074466] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 8.0] [Reference Citation Analysis]
245 Parchami Barjui S, Reiisi S, Ebrahimi S, Shekari B. Study of correlation between genetic variants in three microRNA genes ( hsa-miR-146a, hsa-miR-502 binding site, hsa-miR-27a ) and breast cancer risk. Current Research in Translational Medicine 2017;65:141-7. [DOI: 10.1016/j.retram.2017.10.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
246 Lin CW, Lin PY, Yang PC. Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition. Stem Cells Int 2016;2016:2732705. [PMID: 26989421 DOI: 10.1155/2016/2732705] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
247 Zhang L, Li H, Zang Y, Wang F. NLRP3 inflammasome inactivation driven by miR‑223‑3p reduces tumor growth and increases anticancer immunity in breast cancer. Mol Med Rep 2019;19:2180-8. [PMID: 30747211 DOI: 10.3892/mmr.2019.9889] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
248 Meng L, Liu C, Lü J, Zhao Q, Deng S, Wang G, Qiao J, Zhang C, Zhen L, Lu Y, Li W, Zhang Y, Pestell RG, Fan H, Chen YH, Liu Z, Yu Z. Small RNA zippers lock miRNA molecules and block miRNA function in mammalian cells. Nat Commun 2017;8:13964. [PMID: 28045030 DOI: 10.1038/ncomms13964] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
249 Rai V, Abdo J, Alsuwaidan AN, Agrawal S, Sharma P, Agrawal DK. Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma. Mol Cell Biochem 2018;437:13-36. [DOI: 10.1007/s11010-017-3092-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
250 Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008;3:e2557. [PMID: 18596939 DOI: 10.1371/journal.pone.0002557] [Cited by in Crossref: 455] [Cited by in F6Publishing: 460] [Article Influence: 35.0] [Reference Citation Analysis]
251 Yin B, Liu Y, Ye B. Sensitive Detection of MicroRNA in Complex Biological Samples via Enzymatic Signal Amplification Using DNA Polymerase Coupled with Nicking Endonuclease. Anal Chem 2013;85:11487-93. [DOI: 10.1021/ac403302a] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 8.9] [Reference Citation Analysis]
252 Gu J, Zhang J, Zheng L, Ajani JA, Wu X, Ye Y. Serum miR-331-3p predicts tumor recurrence in esophageal adenocarcinoma. Sci Rep. 2018;8:14006. [PMID: 30228315 DOI: 10.1038/s41598-018-32282-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
253 Sun YM, Lin KY, Chen YQ. Diverse functions of miR-125 family in different cell contexts. J Hematol Oncol 2013;6:6. [PMID: 23321005 DOI: 10.1186/1756-8722-6-6] [Cited by in Crossref: 215] [Cited by in F6Publishing: 217] [Article Influence: 26.9] [Reference Citation Analysis]
254 Wu Q, Zhou W, Feng Q, Liu X, Xiong Y, Li H. MicroRNA-92b promotes cell proliferation and invasion in osteosarcoma by directly targeting Dickkopf-related protein 3. Exp Ther Med 2018;15:173-81. [PMID: 29250147 DOI: 10.3892/etm.2017.5356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
255 Shivram H, Le SV, Iyer VR. PRC2 activates interferon-stimulated genes indirectly by repressing miRNAs in glioblastoma. PLoS One 2019;14:e0222435. [PMID: 31513636 DOI: 10.1371/journal.pone.0222435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
256 Ren W, Qiang C, Gao L, Li S, Zhang L, Wang X, Dong J, Chen C, Liu C, Zhi K. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma. Biomarkers 2014;19:590-6. [DOI: 10.3109/1354750x.2014.955059] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 3.9] [Reference Citation Analysis]
257 Gumireddy K, Li A, Yan J, Setoyama T, Johannes GJ, Orom UA, Tchou J, Liu Q, Zhang L, Speicher DW, Calin GA, Huang Q. Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step. EMBO J 2013;32:2672-84. [PMID: 23974796 DOI: 10.1038/emboj.2013.188] [Cited by in Crossref: 106] [Cited by in F6Publishing: 107] [Article Influence: 13.3] [Reference Citation Analysis]
258 Drusco A, Bottoni A, Laganà A, Acunzo M, Fassan M, Cascione L, Antenucci A, Kumchala P, Vicentini C, Gardiman MP, Alder H, Carosi MA, Ammirati M, Gherardi S, Luscrì M, Carapella C, Zanesi N, Croce CM. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies. Oncotarget 2015;6:20829-39. [PMID: 26246487 DOI: 10.18632/oncotarget.4096] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 11.8] [Reference Citation Analysis]
259 Kogure A, Kosaka N, Ochiya T. Cross-talk between cancer cells and their neighbors via miRNA in extracellular vesicles: an emerging player in cancer metastasis. J Biomed Sci 2019;26:7. [PMID: 30634952 DOI: 10.1186/s12929-019-0500-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 50] [Article Influence: 21.5] [Reference Citation Analysis]
260 Xu S, Wang T, Yang Z, Li Y, Li W, Wang T, Wang S, Jia L, Zhang S, Li S. miR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13. Oncotarget 2016;7:45687-701. [PMID: 27285768 DOI: 10.18632/oncotarget.9920] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
261 Sanfiorenzo C, Ilie MI, Belaid A, Barlési F, Mouroux J, Marquette CH, Brest P, Hofman P. Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS One. 2013;8:e54596. [PMID: 23342174 DOI: 10.1371/journal.pone.0054596] [Cited by in Crossref: 121] [Cited by in F6Publishing: 122] [Article Influence: 15.1] [Reference Citation Analysis]
262 Pan J, Lu F, Xu H, Wang Q, Lin C, Zhang S. Low p21 level is necessary for the suppressive effects of micoRNA-31 on glioma cell migration and invasion. Tumour Biol 2016;37:9663-70. [PMID: 26801671 DOI: 10.1007/s13277-016-4788-5] [Reference Citation Analysis]
263 Karmakar M, Lai PC, Sinha S, Glaser S, Chakraborty S. Identification of miR-203a, mir-10a, and miR-194 as predictors for risk of lymphovascular invasion in head and neck cancers. Oncotarget 2021;12:1499-519. [PMID: 34316330 DOI: 10.18632/oncotarget.28022] [Reference Citation Analysis]
264 Xue T, Bongu SR, Huang H, Liang W, Wang Y, Zhang F, Liu Z, Zhang Y, Zhang H, Cui X. Ultrasensitive detection of microRNA using a bismuthene-enabled fluorescence quenching biosensor. Chem Commun (Camb) 2020;56:7041-4. [PMID: 32453808 DOI: 10.1039/d0cc01004a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
265 Li J, Li P, Chen T, Gao G, Chen X, Du Y, Zhang R, Yang R, Zhao W, Dun S, Gao F, Zhang G. Expression of microRNA-96 and its potential functions by targeting FOXO3 in non-small cell lung cancer. Tumour Biol 2015;36:685-92. [PMID: 25286764 DOI: 10.1007/s13277-014-2698-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
266 Li A, Zhang J, Yu X, Li J, Qiu J, Zhao Z, Guo W, Claverie JP, Mou X, Liu H. An Impedimetric-Fluorescence Double-Checking Biosensor with Enhanced Reliability Based on Graphene Oxide. Adv Mater Interfaces 2015;2:1500279. [DOI: 10.1002/admi.201500279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
267 Romeo P, Colombo C, Granata R, Calareso G, Gualeni AV, Dugo M, De Cecco L, Rizzetti MG, Zanframundo A, Aiello A, Carcangiu ML, Gloghini A, Ferrero S, Licitra L, Greco A, Fugazzola L, Locati LD, Borrello MG. Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients. Endocr Relat Cancer 2018;25:217-31. [PMID: 29298817 DOI: 10.1530/ERC-17-0389] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
268 Pöhlmann C, Sprinzl M. Electrochemical Detection of RNA. In: Erdmann VA, Jurga S, Barciszewski J, editors. RNA and DNA Diagnostics. Cham: Springer International Publishing; 2015. pp. 21-45. [DOI: 10.1007/978-3-319-17305-4_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
269 You ZH, Wang LP, Chen X, Zhang S, Li XF, Yan GY, Li ZW. PRMDA: personalized recommendation-based MiRNA-disease association prediction. Oncotarget 2017;8:85568-83. [PMID: 29156742 DOI: 10.18632/oncotarget.20996] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
270 Zhao H, Guo M, Zhao G, Ma Q, Ma B, Qiu X, Fan Q. miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells. Int J Mol Med 2012;30:1013-20. [PMID: 22922800 DOI: 10.3892/ijmm.2012.1111] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
271 Park J, Yeo JS. Colorimetric detection of microRNA miR-21 based on nanoplasmonic core-satellite assembly. Chem Commun (Camb) 2014;50:1366-8. [PMID: 24346179 DOI: 10.1039/c3cc48154a] [Cited by in Crossref: 41] [Cited by in F6Publishing: 6] [Article Influence: 5.9] [Reference Citation Analysis]
272 Hooykaas MJG, Soppe JA, De Buhr HM, Kruse E, Wiertz EJHJ, Lebbink RJ. RNA accessibility impacts potency of Tough Decoy microRNA inhibitors. RNA Biol 2018;15:1410-9. [PMID: 30339041 DOI: 10.1080/15476286.2018.1537746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
273 Kuo PL, Liao SH, Hung JY, Huang MS, Hsu YL. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. Biochim Biophys Acta. 2013;1830:3756-3766. [PMID: 23458685 DOI: 10.1016/j.bbagen.2013.02.022] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 8.6] [Reference Citation Analysis]
274 Zhu SL, Zhong JH, Gong WF, Li H, Li LQ. Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis. Onco Targets Ther 2016;9:2111-9. [PMID: 27143913 DOI: 10.2147/OTT.S96738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
275 Zhang J, Xie S, Ma W, Teng Y, Tian Y, Huang X, Zhang Y. A newly identified microRNA, mmu-miR-7578, functions as a negative regulator on inflammatory cytokines tumor necrosis factor-α and interleukin-6 via targeting Egr1 in vivo. J Biol Chem 2013;288:4310-20. [PMID: 23184950 DOI: 10.1074/jbc.M112.351197] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
276 Yuan W, Guo YQ, Li XY, Deng MZ, Shen ZH, Bo CB, Dai YF, Huang MY, Yang ZY, Quan YS, Tian L, Wang X. MicroRNA-126 inhibits colon cancer cell proliferation and invasion by targeting the chemokine (C-X-C motif) receptor 4 and Ras homolog gene family, member A, signaling pathway. Oncotarget 2016;7:60230-44. [PMID: 27517626 DOI: 10.18632/oncotarget.11176] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
277 Yang J, Lan H, Huang X, Liu B, Tong Y. MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients. PLoS One. 2012;7:e42978. [PMID: 22900072 DOI: 10.1371/journal.pone.0042978] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
278 Schneider A, Dhahbi JM, Atamna H, Clark JP, Colman RJ, Anderson RM. Caloric restriction impacts plasma microRNAs in rhesus monkeys. Aging Cell 2017;16:1200-3. [PMID: 28677323 DOI: 10.1111/acel.12636] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
279 Li R, Yin B, Ye B. Ultrasensitive, colorimetric detection of microRNAs based on isothermal exponential amplification reaction-assisted gold nanoparticle amplification. Biosensors and Bioelectronics 2016;86:1011-6. [DOI: 10.1016/j.bios.2016.07.042] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 16.2] [Reference Citation Analysis]
280 Zhang Q, Fan H, Zou Q, Liu H, Wan B, Zhu S, Hu Y, Li H, Zhang C, Zhou L, Zhu Q, Xiao K, Zhang J, Zhan P, Lv T, Song Y. TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression. J Cell Mol Med 2018;22:3560-71. [PMID: 29667772 DOI: 10.1111/jcmm.13634] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
281 Goyal R, Kapadia CH, Melamed JR, Riley RS, Day ES. Layer-by-layer assembled gold nanoshells for the intracellular delivery of miR-34a. Cell Mol Bioeng 2018;11:383-96. [PMID: 30555597 DOI: 10.1007/s12195-018-0535-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
282 Gao Y, Zhao H, Lu Y, Li H, Yan G. MicroRNAs as potential diagnostic biomarkers in renal cell carcinoma. Tumour Biol 2014;35:11041-50. [PMID: 25095976 DOI: 10.1007/s13277-014-2381-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
283 Ji J, Zheng X, Forgues M, Yamashita T, Wauthier EL, Reid LM, Wen X, Song Y, Wei JS, Khan J. Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma. Hepatology. 2015;62:829-840. [PMID: 25953724 DOI: 10.1002/hep.27886] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
284 Wang X, Liu L, Wu H, Wu Z, Tang LJ, Jiang JH. Programming DNA cascade circuits on live cell membranes for accurate cancer cell recognition and gene silencing. Chem Commun (Camb) 2021;57:3816-9. [PMID: 33876130 DOI: 10.1039/d1cc00481f] [Reference Citation Analysis]
285 Prasanth KV, Camiolo M, Chan G, Tripathi V, Denis L, Nakamura T, Hübner MR, Spector DL. Nuclear organization and dynamics of 7SK RNA in regulating gene expression. Mol Biol Cell 2010;21:4184-96. [PMID: 20881057 DOI: 10.1091/mbc.E10-02-0105] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
286 Li X, Wu P, Tang Y, Fan Y, Liu Y, Fang X, Wang W, Zhao S. Down-Regulation of MiR-181c-5p Promotes Epithelial-to-Mesenchymal Transition in Laryngeal Squamous Cell Carcinoma via Targeting SERPINE1. Front Oncol 2020;10:544476. [PMID: 33680908 DOI: 10.3389/fonc.2020.544476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
287 Zheng B, Liang L, Huang S, Zha R, Liu L, Jia D, Tian Q, Wang Q, Wang C, Long Z. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene. 2012;31:4509-4516. [PMID: 22179828 DOI: 10.1038/onc.2011.581] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 8.3] [Reference Citation Analysis]
288 Ahmed FE. miRNA as markers for the diagnostic screening of colon cancer. Expert Rev Anticancer Ther 2014;14:463-85. [PMID: 24580550 DOI: 10.1586/14737140.2014.869479] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
289 Li L, Zhang H, Wang X, Wang J, Wei H. Long non-coding RNA CASC2 enhanced cisplatin-induced viability inhibition of non-small cell lung cancer cells by regulating the PTEN/PI3K/Akt pathway through down-regulation of miR-18a and miR-21. RSC Adv 2018;8:15923-32. [DOI: 10.1039/c8ra00549d] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
290 Ivan M, Huang X. miR-210: fine-tuning the hypoxic response. Adv Exp Med Biol. 2014;772:205-227. [PMID: 24272361 DOI: 10.1007/978-1-4614-5915-6_10] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 10.0] [Reference Citation Analysis]
291 Jiang YW, Chen LA. microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (review). Mol Med Rep 2012;5:890-4. [PMID: 22307769 DOI: 10.3892/mmr.2012.776] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
292 Polonyi C, Elmroth SKC. Time dependence of cisplatin-induced duplex dissociation of 15-mer RNAs and mature miR-146a. Dalton Trans 2013;42:14959. [DOI: 10.1039/c3dt51788h] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
293 Altomare DA, Rybak SM, Pei J, Maizel JV, Cheung M, Testa JR, Shogen K. Onconase responsive genes in human mesothelioma cells: implications for an RNA damaging therapeutic agent. BMC Cancer 2010;10:34. [PMID: 20137089 DOI: 10.1186/1471-2407-10-34] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
294 Wu P, Agnelli L, Walker BA, Todoerti K, Lionetti M, Johnson DC, Kaiser M, Mirabella F, Wardell C, Gregory WM, Davies FE, Brewer D, Neri A, Morgan GJ. Improved risk stratification in myeloma using a microRNA-based classifier. Br J Haematol 2013;162:348-59. [PMID: 23718138 DOI: 10.1111/bjh.12394] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.8] [Reference Citation Analysis]
295 Chen H, Sun LY, Chen LL, Zheng HQ, Zhang QF. A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese. Intern Med J. 2012;42:e115-e119. [PMID: 21241442 DOI: 10.1111/j.1445-5994.2011.02434.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
296 Balch C, Matei DE, Huang TH, Nephew KP. Role of epigenomics in ovarian and endometrial cancers. Epigenomics 2010;2:419-47. [PMID: 22121902 DOI: 10.2217/epi.10.19] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
297 Qin Y, Zhang Y, Tang Q, Jin L, Chen Y. SQLE induces epithelial-to-mesenchymal transition by regulating of miR-133b in esophageal squamous cell carcinoma. Acta Biochim Biophys Sin (Shanghai) 2017;49:138-48. [PMID: 28069586 DOI: 10.1093/abbs/gmw127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
298 Wang L, Shang C, Pan H, Yang H, Zhu H, Gong F. MicroRNA Expression Profiles in the Subcutaneous Adipose Tissues of Morbidly Obese Chinese Women. Obes Facts 2021;:1-15. [PMID: 33550286 DOI: 10.1159/000511772] [Reference Citation Analysis]
299 Lee NP, Cheung ST, Poon RT, Fan ST, Luk JM. Genomic and proteomic biomarkers for diagnosis and prognosis of hepatocellular carcinoma. Biomark Med 2007;1:273-84. [PMID: 20477402 DOI: 10.2217/17520363.1.2.273] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
300 Miyachi M, Tsuchiya K, Hosono A, Ogawa A, Koh K, Kikuta A, Hara J, Teramukai S, Hosoi H. Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma: A study protocol. Medicine (Baltimore) 2019;98:e18344. [PMID: 31876708 DOI: 10.1097/MD.0000000000018344] [Reference Citation Analysis]
301 Zhou Q, Zuo M, He Z, Li H, Li W. Identification of circulating microRNAs as diagnostic biomarkers for ovarian cancer: A pooled analysis of individual studies. Int J Biol Markers 2018;33:379-88. [DOI: 10.1177/1724600818766500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
302 Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H, Liu X, Le H, Zhang Y. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer. PLoS One 2016;11:e0153046. [PMID: 27093275 DOI: 10.1371/journal.pone.0153046] [Cited by in Crossref: 62] [Cited by in F6Publishing: 74] [Article Influence: 12.4] [Reference Citation Analysis]
303 Chen X, Yan GY. Semi-supervised learning for potential human microRNA-disease associations inference. Sci Rep 2014;4:5501. [PMID: 24975600 DOI: 10.1038/srep05501] [Cited by in Crossref: 213] [Cited by in F6Publishing: 196] [Article Influence: 30.4] [Reference Citation Analysis]
304 Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011;8:467-477. [PMID: 21647195 DOI: 10.1038/nrclinonc.2011.76] [Cited by in Crossref: 916] [Cited by in F6Publishing: 891] [Article Influence: 91.6] [Reference Citation Analysis]
305 Wang DY, Gendoo DMA, Ben-David Y, Woodgett JR, Zacksenhaus E. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling. Breast Cancer Res 2019;21:18. [PMID: 30704524 DOI: 10.1186/s13058-019-1098-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
306 Rager JE, Smeester L, Jaspers I, Sexton KG, Fry RC. Epigenetic changes induced by air toxics: formaldehyde exposure alters miRNA expression profiles in human lung cells. Environ Health Perspect. 2011;119:494-500. [PMID: 21147603 DOI: 0.1289/ehp.1002614] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
307 Tian W, Wu W, Li X, Rui X, Wu Y. MiRNA-139-3p inhibits the proliferation, invasion, and migration of human glioma cells by targeting MDA-9/syntenin. Biochem Biophys Res Commun 2019;508:295-301. [PMID: 30502089 DOI: 10.1016/j.bbrc.2018.11.144] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
308 O'Sullivan JF, Martin K, Caplice NM. Microribonucleic acids for prevention of plaque rupture and in-stent restenosis: "a finger in the dam". J Am Coll Cardiol 2011;57:383-9. [PMID: 21251577 DOI: 10.1016/j.jacc.2010.09.029] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
309 Liu H, Li L, Wang Q, Duan L, Tang B. Graphene Fluorescence Switch-Based Cooperative Amplification: A Sensitive and Accurate Method to Detection MicroRNA. Anal Chem 2014;86:5487-93. [DOI: 10.1021/ac500752t] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 11.1] [Reference Citation Analysis]
310 Wang J, Wang Z, Yuan J, Wang Q, Shen X. Upregulation of miR-137 Expression Suppresses Tumor Growth and Progression via Interacting with DNMT3a Through Inhibiting the PTEN/Akt Signaling in HCC. Onco Targets Ther 2021;14:165-76. [PMID: 33447058 DOI: 10.2147/OTT.S268570] [Reference Citation Analysis]
311 Shi X, Zhang Y, Cao B, Lu N, Feng L, Di X, Han N, Luo C, Wang G, Cheng S, Zhang K. Genes involved in the transition from normal epithelium to intraepithelial neoplasia are associated with colorectal cancer patient survival. Biochem Biophys Res Commun 2013;435:282-8. [PMID: 23628414 DOI: 10.1016/j.bbrc.2013.04.063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
312 Alsidawi S, Malek E, Driscoll JJ. MicroRNAs in brain metastases: potential role as diagnostics and therapeutics. Int J Mol Sci 2014;15:10508-26. [PMID: 24921708 DOI: 10.3390/ijms150610508] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
313 Zhang P, Zhang J, Wang C, Liu C, Wang H, Li Z. Highly sensitive and specific multiplexed microRNA quantification using size-coded ligation chain reaction. Anal Chem. 2014;86:1076-1082. [PMID: 24364819 DOI: 10.1021/ac4026384] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 9.3] [Reference Citation Analysis]
314 Wu ZH, Pfeffer LM. MicroRNA regulation of F-box proteins and its role in cancer. Semin Cancer Biol 2016;36:80-7. [PMID: 26433073 DOI: 10.1016/j.semcancer.2015.09.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
315 Chawla JP, Iyer N, Soodan KS, Sharma A, Khurana SK, Priyadarshni P. Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer. Oral Oncol 2015;51:731-7. [PMID: 26093389 DOI: 10.1016/j.oraloncology.2015.05.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
316 Zhou Y, Wang M, Wu J, Jie Z, Chang S, Shuang T. The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer. J Ovarian Res 2015;8:23. [PMID: 25887170 DOI: 10.1186/s13048-015-0143-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
317 Song L, Huang Q, Chen K, Liu L, Lin C, Dai T, Yu C, Wu Z, Li J. miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β. Biochem Biophys Res Commun. 2010;402:135-140. [PMID: 20933503 DOI: 10.1016/j.bbrc.2010.10.003] [Cited by in Crossref: 106] [Cited by in F6Publishing: 99] [Article Influence: 9.6] [Reference Citation Analysis]
318 Yuxia M, Zhennan T, Wei Z. Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis. J Cancer Res Clin Oncol. 2012;138:2045-2050. [PMID: 22806310 DOI: 10.1007/s00432-012-1285-0] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 10.6] [Reference Citation Analysis]
319 Chen Y, Kitabayashi N, Zhou XK, Fahey TJ, Scognamiglio T. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 2008;21:1139-46. [DOI: 10.1038/modpathol.2008.105] [Cited by in Crossref: 140] [Cited by in F6Publishing: 122] [Article Influence: 10.8] [Reference Citation Analysis]
320 Li LY, Xiao J, Liu Q, Xia K. Parecoxib inhibits glioblastoma cell proliferation, migration and invasion by upregulating miRNA-29c. Biol Open 2017;6:311-6. [PMID: 27895048 DOI: 10.1242/bio.021410] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
321 Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 2013;21:185-191. [PMID: 23032975 DOI: 10.1038/mt.2012.180] [Cited by in Crossref: 839] [Cited by in F6Publishing: 844] [Article Influence: 93.2] [Reference Citation Analysis]
322 Zhang H. Reversal of HIV-1 latency with anti-microRNA inhibitors. Int J Biochem Cell Biol 2009;41:451-4. [PMID: 18761423 DOI: 10.1016/j.biocel.2008.07.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
323 Sonkoly E, Ståhle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008;18:131-40. [PMID: 18291670 DOI: 10.1016/j.semcancer.2008.01.005] [Cited by in Crossref: 376] [Cited by in F6Publishing: 378] [Article Influence: 28.9] [Reference Citation Analysis]
324 Dahiya N, Morin PJ. MicroRNAs in ovarian carcinomas. Endocr Relat Cancer 2010;17:F77-89. [PMID: 19903743 DOI: 10.1677/ERC-09-0203] [Cited by in Crossref: 70] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
325 Huang J, Dong B, Zhang J, Kong W, Chen Y, Xue W, Liu D, Huang Y. miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma. Tumour Biol 2014;35:5833-43. [PMID: 24609899 DOI: 10.1007/s13277-014-1774-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
326 Michaille JJ, Awad H, Fortman EC, Efanov AA, Tili E. miR-155 expression in antitumor immunity: The higher the better? Genes Chromosomes Cancer 2019;58:208-18. [PMID: 30382602 DOI: 10.1002/gcc.22698] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
327 Llauradó M, Majem B, Altadill T, Lanau L, Castellví J, Sánchez-iglesias JL, Cabrera S, De la Torre J, Díaz-feijoo B, Pérez-benavente A, Colás E, Olivan M, Doll A, Alameda F, Matias-guiu X, Moreno-bueno G, Carey MS, Del Campo JM, Gil-moreno A, Reventós J, Rigau M. MicroRNAs as prognostic markers in ovarian cancer. Molecular and Cellular Endocrinology 2014;390:73-84. [DOI: 10.1016/j.mce.2014.03.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
328 Yang M, Liu R, Li X, Liao J, Pu Y, Pan E, Yin L, Wang Y. miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4. Mol Cells 2014;37:873-80. [PMID: 25518924 DOI: 10.14348/molcells.2014.0147] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
329 Chun HE, Lim EL, Heravi-Moussavi A, Saberi S, Mungall KL, Bilenky M, Carles A, Tse K, Shlafman I, Zhu K, Qian JQ, Palmquist DL, He A, Long W, Goya R, Ng M, LeBlanc VG, Pleasance E, Thiessen N, Wong T, Chuah E, Zhao YJ, Schein JE, Gerhard DS, Taylor MD, Mungall AJ, Moore RA, Ma Y, Jones SJM, Perlman EJ, Hirst M, Marra MA. Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways. Cancer Cell 2016;29:394-406. [PMID: 26977886 DOI: 10.1016/j.ccell.2016.02.009] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 15.8] [Reference Citation Analysis]
330 Wang YW, Zhang W, Ma R. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data. Oncol Rep 2018;39:1003-10. [PMID: 29328395 DOI: 10.3892/or.2018.6205] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
331 Belbin TJ, Bergman A, Brandwein-Gensler M, Chen Q, Childs G, Garg M, Haigentz M, Hogue-Angeletti R, Moadel R, Negassa A, Owen R, Prystowsky MB, Schiff B, Schlecht NF, Shifteh K, Smith RV, Zheng X. Head and neck cancer: reduce and integrate for optimal outcome. Cytogenet Genome Res 2007;118:92-109. [PMID: 18000360 DOI: 10.1159/000108290] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
332 Ho JY, Hsu RJ, Liu JM, Chen SC, Liao GS, Gao HW, Yu CP. MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis. Oncotarget 2017;8:22443-59. [PMID: 27705918 DOI: 10.18632/oncotarget.12338] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
333 Zhao L, Chen X, Cao Y. miRNA and nasopharyngeal carcinoma. Chin Sci Bull 2011;56:722-8. [DOI: 10.1007/s11434-010-4330-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
334 Nasr MA, Salah RA, Abd Elkodous M, Elshenawy SE, El-Badri N. Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells. Front Cell Dev Biol 2019;7:229. [PMID: 31681762 DOI: 10.3389/fcell.2019.00229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
335 Kirhan I, Kas F, Taskiran H, Buyukhatipoglu H, Gönel A, Koyuncu I. Evaluation of Micro-RNA Levels, Apoptosis and Oxidative Stress Markers in Patients Recieving Chemotherapy. Comb Chem High Throughput Screen 2020;23:17-27. [PMID: 31889481 DOI: 10.2174/1386207323666191224111348] [Reference Citation Analysis]
336 Feng J, Iwama A, Satake M, Kohu K. MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1. Br J Haematol 2009;145:412-23. [PMID: 19298589 DOI: 10.1111/j.1365-2141.2009.07632.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 4.7] [Reference Citation Analysis]
337 Kim JJ, Chen L, Doyle PS. Microparticle parking and isolation for highly sensitive microRNA detection. Lab Chip 2017;17:3120-8. [PMID: 28815227 DOI: 10.1039/c7lc00653e] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
338 Wang J, Dan G, Zhao J, Ding Y, Ye F, Sun H, Jiang F, Cheng J, Yuan F, Zou Z. The predictive effect of overexpressed miR-34a on good survival of cancer patients: a systematic review and meta-analysis. Onco Targets Ther 2015;8:2709-19. [PMID: 26445554 DOI: 10.2147/OTT.S84043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
339 Liang C, Wang Z, Li Y, Yu B, Zhang F, Li H. miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells. Tumor Biol 2015;36:9395-403. [DOI: 10.1007/s13277-015-3679-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
340 Yang X, Wu L, Lin J, Wang A, Wan X, Wu Y, Robson SC, Sang X, Zhao H. Distinct hepatitis B virus integration patterns in hepatocellular carcinoma and adjacent normal liver tissue. Int J Cancer 2017;140:1324-30. [PMID: 27943263 DOI: 10.1002/ijc.30547] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
341 Gebeshuber CA, Zatloukal K, Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep. 2009;10:400-405. [PMID: 19247375 DOI: 10.1038/embor.2009.9] [Cited by in Crossref: 281] [Cited by in F6Publishing: 277] [Article Influence: 23.4] [Reference Citation Analysis]
342 Aparicio O, Carnero E, Abad X, Razquin N, Guruceaga E, Segura V, Fortes P. Adenovirus VA RNA-derived miRNAs target cellular genes involved in cell growth, gene expression and DNA repair. Nucleic Acids Res 2010;38:750-63. [PMID: 19933264 DOI: 10.1093/nar/gkp1028] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
343 Kawaguchi T, Yan L, Qi Q, Peng X, Edge SB, Young J, Yao S, Liu S, Otsuji E, Takabe K. Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer. Ann Surg Oncol 2018;25:4037-46. [PMID: 30311168 DOI: 10.1245/s10434-018-6859-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
344 Bettazzi F, Hamid-Asl E, Esposito CL, Quintavalle C, Formisano N, Laschi S, Catuogno S, Iaboni M, Marrazza G, Mascini M, Cerchia L, De Franciscis V, Condorelli G, Palchetti I. Electrochemical detection of miRNA-222 by use of a magnetic bead-based bioassay. Anal Bioanal Chem 2013;405:1025-34. [PMID: 23099529 DOI: 10.1007/s00216-012-6476-7] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 10.7] [Reference Citation Analysis]
345 Chen B, Zhang D, Kuai J, Cheng M, Fang X, Li G. Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1+ colorectal cancer stem cells. Tumour Biol 2017;39:1010428317715155. [PMID: 28639895 DOI: 10.1177/1010428317715155] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
346 Deng Y, Deng H, Bi F, Liu J, Bemis LT, Norris D, Wang XJ, Zhang Q. MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines. Int J Biol Sci 2011;7:133-7. [PMID: 21278922 DOI: 10.7150/ijbs.7.133] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
347 Rokah OH, Granot G, Ovcharenko A, Modai S, Pasmanik-Chor M, Toren A, Shomron N, Shpilberg O. Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells. PLoS One 2012;7:e35501. [PMID: 22511990 DOI: 10.1371/journal.pone.0035501] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
348 Zhao Y, Wang H, Wu C, Yan M, Wu H, Wang J, Yang X, Shao Q. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer. Oncol Rep 2018;39:1197-206. [PMID: 29328463 DOI: 10.3892/or.2018.6207] [Cited by in Crossref: 15] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
349 Zhang SY, Lu ZM, Lin YF, Chen LS, Luo XN, Song XH, Chen SH, Wu YL. miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma. Oncotarget 2016;7:11637-50. [PMID: 26826553 DOI: 10.18632/oncotarget.7025] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
350 Shiina M, Hashimoto Y, Kulkarni P, Dasgupta P, Shahryari V, Yamamura S, Tanaka Y, Dahiya R. Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans. BMC Cancer 2021;21:1028. [PMID: 34525952 DOI: 10.1186/s12885-021-08723-6] [Reference Citation Analysis]
351 Asanov A, Sampieri A, Vaca L. Developing a Portable Device for the Identification of miRNAs in Fluids. Methods Mol Biol 2021;2174:73-88. [PMID: 32813245 DOI: 10.1007/978-1-0716-0759-6_6] [Reference Citation Analysis]
352 Zhang C. MicroRNAs: role in cardiovascular biology and disease. Clinical Science 2008;114:699-706. [DOI: 10.1042/cs20070211] [Cited by in Crossref: 84] [Cited by in F6Publishing: 40] [Article Influence: 6.5] [Reference Citation Analysis]
353 Jiang L, Cheng Q, Zhang BH, Zhang MZ. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China. Medicine (Baltimore). 2015;94:e603. [PMID: 25761179 DOI: 10.1097/md.0000000000000603] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
354 Hashemi‐moghaddam H, Kashi M, Mowla SJ, Nouraee N. Separation of microRNA 21 as a cancer marker from glioblastoma cell line using molecularly imprinted polymer coated on silica nanoparticles. J Sep Science 2016;39:3564-70. [DOI: 10.1002/jssc.201600736] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
355 Kang H, Kim C, Lee H, Rho JG, Seo JW, Nam JW, Song WK, Nam SW, Kim W, Lee EK. Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer. Cell Death Differ 2016;23:484-95. [PMID: 26337669 DOI: 10.1038/cdd.2015.116] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
356 Shen N, Huang X, Li J. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression. Tumour Biol. 2016;37:1789-1796. [PMID: 26318305 DOI: 10.1007/s13277-015-3969-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
357 Fan HX, Feng YJ, Zhao XP, He YZ, Tang H. MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells. Life Sci. 2018;213:9-17. [PMID: 30308183 DOI: 10.1016/j.lfs.2018.10.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
358 Nadal E, Truini A, Nakata A, Lin J, Reddy RM, Chang AC, Ramnath N, Gotoh N, Beer DG, Chen G. A Novel Serum 4-microRNA Signature for Lung Cancer Detection. Sci Rep 2015;5:12464. [PMID: 26202143 DOI: 10.1038/srep12464] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 11.2] [Reference Citation Analysis]
359 Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell. 2012;148:1172-1187. [PMID: 22424228 DOI: 10.1016/j.cell.2012.02.005] [Cited by in Crossref: 1138] [Cited by in F6Publishing: 1079] [Article Influence: 126.4] [Reference Citation Analysis]
360 Si F, Sun J, Wang C. MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling. Exp Ther Med 2017;14:1967-74. [PMID: 28962111 DOI: 10.3892/etm.2017.4733] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
361 Wang C, Zhu G, Yu M, Mi X, Qu H. miR-455 Inhibits the Viability and Invasion by Targeting RAB18 in Hepatocellular Carcinoma. J Oncol 2021;2021:9923454. [PMID: 34135963 DOI: 10.1155/2021/9923454] [Reference Citation Analysis]
362 Gong Y, He T, Yang L, Yang G, Chen Y, Zhang X. The role of miR-100 in regulating apoptosis of breast cancer cells. Sci Rep 2015;5:11650. [PMID: 26130569 DOI: 10.1038/srep11650] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 8.3] [Reference Citation Analysis]
363 Qiu L, Zhang Y, Liu C, Li Z. A versatile size-coded flow cytometric bead assay for simultaneous detection of multiple microRNAs coupled with a two-step cascading signal amplification. Chem Commun 2017;53:2926-9. [DOI: 10.1039/c7cc00618g] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
364 Sümbül AT, Göğebakan B, Bayram S, Batmacı CY, Öztuzcu S. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study. Tumour Biol 2015;36:9703-9. [PMID: 26152286 DOI: 10.1007/s13277-015-3708-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
365 Zhou M, Hou Y, Wu J, Li G, Cao P, Chen W, Hu L, Gan D. miR-93-5p promotes insulin resistance to regulate type 2 diabetes progression in HepG2 cells by targeting HGF. Mol Med Rep 2021;23:329. [PMID: 33760164 DOI: 10.3892/mmr.2021.11968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
366 Wang YY, Sun G, Luo H, Wang XF, Lan FM, Yue X, Fu LS, Pu PY, Kang CS, Liu N, You YP. MiR-21 modulates hTERT through a STAT3-dependent manner on glioblastoma cell growth. CNS Neurosci Ther 2012;18:722-8. [PMID: 22709411 DOI: 10.1111/j.1755-5949.2012.00349.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
367 Song W, Wenhui Z, Ruiqiang Y, Hu X, Shi T, Wang M, Zhang H. Long noncoding RNA PP7080 promotes hepatocellular carcinoma development by sponging mir-601 and targeting SIRT1. Bioengineered 2021;12:1599-610. [PMID: 33955831 DOI: 10.1080/21655979.2021.1920323] [Reference Citation Analysis]
368 Roufayel R, Kadry S. Expression of miR-23a by apoptotic regulators in human cancer: A review. Cancer Biol Ther 2017;18:269-76. [PMID: 28453394 DOI: 10.1080/15384047.2017.1310342] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
369 Ahmed AA, Essa MEA. Potential of epigenetic events in human thyroid cancer. Cancer Genet 2019;239:13-21. [PMID: 31472323 DOI: 10.1016/j.cancergen.2019.08.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
370 Santarelli L, Strafella E, Staffolani S, Amati M, Emanuelli M, Sartini D, Pozzi V, Carbonari D, Bracci M, Pignotti E, Mazzanti P, Sabbatini A, Ranaldi R, Gasparini S, Neuzil J, Tomasetti M. Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma. PLoS One 2011;6:e18232. [PMID: 21483773 DOI: 10.1371/journal.pone.0018232] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
371 Sun X, Du P, Yuan W, Du Z, Yu M, Yu X, Hu T. Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer. Cell Death Dis 2015;6:e1907. [PMID: 26469956 DOI: 10.1038/cddis.2015.269] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 7.8] [Reference Citation Analysis]
372 Raimondi L, De Luca A, Gallo A, Costa V, Russelli G, Cuscino N, Manno M, Raccosta S, Carina V, Bellavia D, Conigliaro A, Alessandro R, Fini M, Conaldi PG, Giavaresi G. Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs. Carcinogenesis 2020;41:666-77. [PMID: 31294446 DOI: 10.1093/carcin/bgz130] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 25.0] [Reference Citation Analysis]
373 Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007;6:60. [PMID: 17894887 DOI: 10.1186/1476-4598-6-60] [Cited by in Crossref: 472] [Cited by in F6Publishing: 477] [Article Influence: 33.7] [Reference Citation Analysis]
374 Johannessen C, Moi L, Kiselev Y, Pedersen MI, Dalen SM, Braaten T, Busund LT. Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer. PLoS One 2017;12:e0186658. [PMID: 29073169 DOI: 10.1371/journal.pone.0186658] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
375 Papaconstantinou IG, Manta A, Gazouli M, Lyberopoulou A, Lykoudis PM, Polymeneas G, Voros D. Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas. 2013;42:67-71. [PMID: 22850622 DOI: 10.1097/mpa.0b013e3182592ba7] [Cited by in Crossref: 118] [Cited by in F6Publishing: 84] [Article Influence: 14.8] [Reference Citation Analysis]
376 Zhu K, Ding H, Wang W, Liao Z, Fu Z, Hong Y, Zhou Y, Zhang CY, Chen X. Tumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancer. Oncotarget 2016;7:28075-85. [PMID: 27057632 DOI: 10.18632/oncotarget.8576] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 12.7] [Reference Citation Analysis]
377 Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, Pan Z, Kang T, Huang W. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis. 2011;32:1033-1042. [PMID: 21565830 DOI: 10.1093/carcin/bgr081] [Cited by in Crossref: 125] [Cited by in F6Publishing: 123] [Article Influence: 12.5] [Reference Citation Analysis]
378 Kim Y, Kim H, Bang S, Jee S, Jang K. MicroRNA-130b functions as an oncogene and is a predictive marker of poor prognosis in lung adenocarcinoma. Lab Invest 2021;101:155-64. [PMID: 32999430 DOI: 10.1038/s41374-020-00496-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
379 Ying S, Jianjun H, Xue Y, Shuwei Y, Liyuan Z, Jie W, Lixian C. MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1. Oncol Res 2017;25:1421-30. [PMID: 28059051 DOI: 10.3727/096504016X14826089198805] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
380 Shi XB, Tepper CG, White RW. MicroRNAs and prostate cancer. J Cell Mol Med 2008;12:1456-65. [PMID: 18624768 DOI: 10.1111/j.1582-4934.2008.00420.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
381 Zhang P, Zhao Q, Gong K, Long Y, Zhang J, Li Y, Guo X. Downregulation of miR-103a-3p Contributes to Endothelial Progenitor Cell Dysfunction in Deep Vein Thrombosis Through PTEN Targeting. Annals of Vascular Surgery 2020;64:339-46. [DOI: 10.1016/j.avsg.2019.10.048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
382 Feng Z, Xu Q, Chen W. Epigenetic and genetic alterations-based molecular classification of head and neck cancer. Expert Rev Mol Diagn 2012;12:279-90. [PMID: 22468818 DOI: 10.1586/erm.12.19] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
383 Li BL, Lu C, Lu W, Yang TT, Qu J, Hong X, Wan XP. miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer. Med Oncol. 2013;30:484. [PMID: 23392577 DOI: 10.1007/s12032-013-0484-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
384 Yang Y, An R, Feng T, Qin X, Zhang J, Bo Y, Niu B. Skullcapflavone I suppresses proliferation of human lung cancer cells via down-regulating microRNA-21. Experimental and Molecular Pathology 2019;110:104285. [DOI: 10.1016/j.yexmp.2019.104285] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
385 Ewald B, Sampath D, Plunkett W. Nucleoside analogs: molecular mechanisms signaling cell death. Oncogene 2008;27:6522-37. [PMID: 18955977 DOI: 10.1038/onc.2008.316] [Cited by in Crossref: 152] [Cited by in F6Publishing: 135] [Article Influence: 11.7] [Reference Citation Analysis]
386 Han SJ, Marshall V, Barsov E, Quiñones O, Ray A, Labo N, Trivett M, Ott D, Renne R, Whitby D. Kaposi's sarcoma-associated herpesvirus microRNA single-nucleotide polymorphisms identified in clinical samples can affect microRNA processing, level of expression, and silencing activity. J Virol 2013;87:12237-48. [PMID: 24006441 DOI: 10.1128/JVI.01202-13] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
387 Zhong Q, Wang T, Lu P, Zhang R, Zou J, Yuan S. miR-193b promotes cell proliferation by targeting Smad3 in human glioma. J Neurosci Res. 2014;92:619-626. [PMID: 24496888 DOI: 10.1002/jnr.23339] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
388 Jiang C, Hu X, Alattar M, Zhao H. miRNA expression profiles associated with diagnosis and prognosis in lung cancer. Expert Rev Anticancer Ther 2014;14:453-61. [PMID: 24506710 DOI: 10.1586/14737140.2013.870037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
389 Zhao Z, Yu S, Xu M, Li P. Effects of microwave on extracellular vesicles and microRNA in milk. Journal of Dairy Science 2018;101:2932-40. [DOI: 10.3168/jds.2016-12021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
390 Fahim Golestaneh A, Lecker LSM, Schlegel J, Nowrouzi A, Schwager C, Meister S, Weichert W, Debus J, Abdollahi A. Large scale in vivo micro-RNA loss of function screen identified miR-29a, miR-100 and miR-155 as modulators of radioresistance and tumor-stroma communication. Int J Cancer 2019;144:2774-81. [PMID: 30478850 DOI: 10.1002/ijc.32019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
391 Yao J, Zhou E, Wang Y, Xu F, Zhang D, Zhong D. microRNA-200a Inhibits Cell Proliferation by Targeting Mitochondrial Transcription Factor A in Breast Cancer. DNA and Cell Biology 2014;33:291-300. [DOI: 10.1089/dna.2013.2132] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
392 Yamada A, Yu P, Lin W, Okugawa Y, Boland CR, Goel A. A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer. Sci Rep. 2018;8:575. [PMID: 29330370 DOI: 10.1038/s41598-017-18407-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 13.7] [Reference Citation Analysis]
393 Liang Z, Feng A, Shim H. MicroRNA-30c-regulated HDAC9 mediates chemoresistance of breast cancer. Cancer Chemother Pharmacol 2020;85:413-23. [PMID: 31907648 DOI: 10.1007/s00280-019-04024-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
394 D’amato NC, Howe EN, Richer JK. MicroRNA regulation of epithelial plasticity in cancer. Cancer Letters 2013;341:46-55. [DOI: 10.1016/j.canlet.2012.11.054] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
395 Dieci G, Fiorino G, Castelnuovo M, Teichmann M, Pagano A. The expanding RNA polymerase III transcriptome. Trends Genet 2007;23:614-22. [PMID: 17977614 DOI: 10.1016/j.tig.2007.09.001] [Cited by in Crossref: 331] [Cited by in F6Publishing: 304] [Article Influence: 23.6] [Reference Citation Analysis]
396 Zhao L, Lee VHF, Ng MK, Yan H, Bijlsma MF. Molecular subtyping of cancer: current status and moving toward clinical applications. Brief Bioinform 2019;20:572-84. [PMID: 29659698 DOI: 10.1093/bib/bby026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
397 Assumpção MB, Moreira FC, Hamoy IG, Magalhães L, Vidal A, Pereira A, Burbano R, Khayat A, Silva A, Santos S, Demachki S, Ribeiro-Dos-Santos Â, Assumpção P. High-Throughput miRNA Sequencing Reveals a Field Effect in Gastric Cancer and Suggests an Epigenetic Network Mechanism. Bioinform Biol Insights 2015;9:111-7. [PMID: 26244015 DOI: 10.4137/BBI.S24066] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
398 He D, Yue Z, Li G, Chen L, Feng H, Sun J. Low Serum Levels of miR-101 Are Associated with Poor Prognosis of Colorectal Cancer Patients After Curative Resection. Med Sci Monit 2018;24:7475-81. [PMID: 30341274 DOI: 10.12659/MSM.909768] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
399 Wu Q, Wang C, Lu Z, Guo L, Ge Q. Analysis of serum genome-wide microRNAs for breast cancer detection. Clin Chim Acta 2012;413:1058-65. [PMID: 22387599 DOI: 10.1016/j.cca.2012.02.016] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 10.1] [Reference Citation Analysis]
400 Zhang X, Ren D, Wu X, Lin X, Ye L, Lin C, Wu S, Zhu J, Peng X, Song L. miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways. Mol Ther Nucleic Acids 2018;11:142-58. [PMID: 29858050 DOI: 10.1016/j.omtn.2018.01.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 9.7] [Reference Citation Analysis]
401 Di Fiore R, Suleiman S, Pentimalli F, O'Toole SA, O'Leary JJ, Ward MP, Conlon NT, Sabol M, Ozretić P, Erson-Bensan AE, Reed N, Giordano A, Herrington CS, Calleja-Agius J. Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview. Int J Mol Sci 2021;22:3822. [PMID: 33917022 DOI: 10.3390/ijms22083822] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
402 Gee HE, Ivan C, Calin GA, Ivan M. HypoxamiRs and cancer: from biology to targeted therapy. Antioxid Redox Signal 2014;21:1220-38. [PMID: 24111776 DOI: 10.1089/ars.2013.5639] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 7.9] [Reference Citation Analysis]
403 Espina V, Wulfkuhle J, Liotta LA. Application of Laser Microdissection and Reverse-Phase Protein Microarrays to the Molecular Profiling of Cancer Signal Pathway Networks in the Tissue Microenvironment. Clinics in Laboratory Medicine 2009;29:1-13. [DOI: 10.1016/j.cll.2009.03.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
404 Zhou Q, Yang M, Lan H, Yu X. miR-30a negatively regulates TGF-β1-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1. Am J Pathol 2013;183:808-19. [PMID: 23831330 DOI: 10.1016/j.ajpath.2013.05.019] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 8.9] [Reference Citation Analysis]
405 Grimaldi A, Zarone MR, Irace C, Zappavigna S, Lombardi A, Kawasaki H, Caraglia M, Misso G. Non-coding RNAs as a new dawn in tumor diagnosis. Semin Cell Dev Biol 2018;78:37-50. [PMID: 28765094 DOI: 10.1016/j.semcdb.2017.07.035] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
406 Hu X, Li W, Liu G, Wu H, Gao Y, Chen S, He D, Zhang Y. The effect of Bcl-2 siRNA combined with miR-15a oligonucleotides on the growth of Raji cells. Med Oncol 2013;30:430. [PMID: 23307249 DOI: 10.1007/s12032-012-0430-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
407 黄金明, 叶进, 陈立波. MicroRNA与HBV相关性肝癌发生发展关系的研究进展. 世界华人消化杂志 2008; 16(6): 645-652 [DOI: 10.11569/wcjd.v16.i6.645] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
408 Tyczewska A, Kurzyńska-Kokorniak A, Koralewska N, Szopa A, Kietrys AM, Wrzesiński J, Twardowski T, Figlerowicz M. Selection of RNA oligonucleotides that can modulate human dicer activity in vitro. Nucleic Acid Ther 2011;21:333-46. [PMID: 22004415 DOI: 10.1089/nat.2011.0304] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
409 Oneyama C, Okada M. MicroRNAs as the fine-tuners of Src oncogenic signalling. J Biochem 2015;157:431-8. [PMID: 25862810 DOI: 10.1093/jb/mvv036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
410 Tang S, Gu Y, Lu H, Dong H, Zhang K, Dai W, Meng X, Yang F, Zhang X. Highly-sensitive microRNA detection based on bio-bar-code assay and catalytic hairpin assembly two-stage amplification. Analytica Chimica Acta 2018;1004:1-9. [DOI: 10.1016/j.aca.2017.12.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
411 Xu R, Liu T, Zuo L, Guo D, Ye G, Jiang J, Yu X, Zhang S, Hou C. The high expression of miR-31 in lung adenocarcinoma inhibits the malignancy of lung adenocarcinoma tumor stem cells. Biochem Biophys Rep 2021;28:101122. [PMID: 34485716 DOI: 10.1016/j.bbrep.2021.101122] [Reference Citation Analysis]
412 Wang WX, Wilfred BR, Baldwin DA, Isett RB, Ren N, Stromberg A, Nelson PT. Focus on RNA isolation: obtaining RNA for microRNA (miRNA) expression profiling analyses of neural tissue. Biochim Biophys Acta 2008;1779:749-57. [PMID: 18316046 DOI: 10.1016/j.bbagrm.2008.01.005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
413 Zhang P, He H, Bai Y, Liu W, Huang L. Dexmedetomidine suppresses the progression of esophageal cancer via miR-143-3p/epidermal growth factor receptor pathway substrate 8 axis. Anticancer Drugs 2020;31:693-701. [PMID: 32701250 DOI: 10.1097/CAD.0000000000000934] [Reference Citation Analysis]
414 Chen J, Zhang K, Xu Y, Gao Y, Li C, Wang R, Chen L. The role of microRNA-26a in human cancer progression and clinical application. Tumour Biol 2016;37:7095-108. [PMID: 27039398 DOI: 10.1007/s13277-016-5017-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
415 Saito Y, Saito H, Liang G, Friedman JM. Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review. Clin Rev Allergy Immunol 2014;47:128-35. [PMID: 24362548 DOI: 10.1007/s12016-013-8401-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 8.2] [Reference Citation Analysis]
416 Lv J, Xu L, Xu Y, Qiu M, Yang X, Wang J, Yin R, Xu L. [Expression of MiRNA-221 in non-small cell lung cancer tissues and correlation with prognosis]. Zhongguo Fei Ai Za Zhi 2014;17:221-5. [PMID: 24667259 DOI: 10.3779/j.issn.1009-3419.2014.03.07] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
417 Bastos EP, Brentani H, Pereira CA, Polpo A, Lima L, Puga RD, Pasini FS, Osorio CA, Roela RA, Achatz MI, Trapé AP, Gonzalez-Angulo AM, Brentani MM. A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer. PLoS One 2016;11:e0154325. [PMID: 27152840 DOI: 10.1371/journal.pone.0154325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
418 Wei L, Ran F. MicroRNA-20a promotes proliferation and invasion by directly targeting early growth response 2 in non-small cell lung carcinoma. Oncol Lett 2018;15:271-7. [PMID: 29375712 DOI: 10.3892/ol.2017.7299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
419 Vos S, Vesuna F, Raman V, van Diest PJ, van der Groep P. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers. Oncotarget 2015;6:32115-37. [PMID: 26378051 DOI: 10.18632/oncotarget.5617] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
420 Liu HS, Xiao HS. MicroRNAs as potential biomarkers for gastric cancer. World J Gastroenterol 2014; 20(34): 12007-12017 [PMID: 25232237 DOI: 10.3748/wjg.v20.i34.12007] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 76] [Article Influence: 10.0] [Reference Citation Analysis]
421 Chin AR, Fong MY, Somlo G, Wu J, Swiderski P, Wu X, Wang SE. Cross-kingdom inhibition of breast cancer growth by plant miR159. Cell Res 2016;26:217-28. [PMID: 26794868 DOI: 10.1038/cr.2016.13] [Cited by in Crossref: 151] [Cited by in F6Publishing: 132] [Article Influence: 30.2] [Reference Citation Analysis]
422 Wang J, Li J, Chen L, Fan Z, Cheng J. MicroRNA-499 Suppresses the Growth of Hepatocellular Carcinoma by Downregulating Astrocyte Elevated Gene-1. Technol Cancer Res Treat 2020;19:1533033820920253. [PMID: 32691684 DOI: 10.1177/1533033820920253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
423 Kim T, Reitmair A. Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology. Int J Mol Sci. 2013;14:4934-4968. [PMID: 23455466 DOI: 10.3390/ijms14034934] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
424 Sun Q, Chen S, Zhao X, Yan M, Fang Z, Wang H, Zhao J, Sun M, Han X, Chen W, Li X. Dysregulated miR-645 affects the proliferation and invasion of head and neck cancer cell. Cancer Cell Int 2015;15:87. [PMID: 26388702 DOI: 10.1186/s12935-015-0238-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
425 Zhu W, Kan X. Neural network cascade optimizes microRNA biomarker selection for nasopharyngeal cancer prognosis. PLoS One 2014;9:e110537. [PMID: 25310846 DOI: 10.1371/journal.pone.0110537] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
426 Xu X, Chen W, Miao R, Zhou Y, Wang Z, Zhang L, Wan Y, Dong Y, Qu K, Liu C. miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway. Oncotarget 2015;6:3988-4004. [PMID: 25686834 DOI: 10.18632/oncotarget.2905] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 12.8] [Reference Citation Analysis]
427 Bhat SA, Majid S, Rehman MU. Scenario and future prospects of microRNAs in gastric cancer: A review. Iran J Basic Med Sci 2019;22:345-52. [PMID: 31168337 DOI: 10.22038/ijbms.2019.32399.7765] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
428 Geraldo MV, Yamashita AS, Kimura ET. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. Oncogene. 2012;31:1910-1922. [PMID: 21874046 DOI: 10.1038/onc.2011.381] [Cited by in Crossref: 131] [Cited by in F6Publishing: 128] [Article Influence: 13.1] [Reference Citation Analysis]
429 Yu D, Green B, Marrone A, Guo Y, Kadlubar S, Lin D, Fuscoe J, Pogribny I, Ning B. Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma. Sci Rep 2015;5:8534. [PMID: 25704921 DOI: 10.1038/srep08534] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 10.0] [Reference Citation Analysis]
430 Li B, Shi C, Li B, Zhao JM, Wang L. The effects of Curcumin on HCT-116 cells proliferation and apoptosis via the miR-491/PEG10 pathway. J Cell Biochem 2018;119:3091-8. [PMID: 29058812 DOI: 10.1002/jcb.26449] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
431 Wang J, Chen C, Yan X, Wang P. The role of miR-382-5p in glioma cell proliferation, migration and invasion. Onco Targets Ther 2019;12:4993-5002. [PMID: 31417288 DOI: 10.2147/OTT.S196322] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
432 Li X, Wang Q, Zheng Y, Lv S, Ning S, Sun J, Huang T, Zheng Q, Ren H, Xu J, Wang X, Li Y. Prioritizing human cancer microRNAs based on genes' functional consistency between microRNA and cancer. Nucleic Acids Res 2011;39:e153. [PMID: 21976726 DOI: 10.1093/nar/gkr770] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
433 Yi JM. DNA Methylation Change Profiling of Colorectal Disease: Screening towards Clinical Use. Life (Basel) 2021;11:412. [PMID: 33946400 DOI: 10.3390/life11050412] [Reference Citation Analysis]
434 Permuth-Wey J, Kim D, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, Birrer MJ, Bloom G, Chanock SJ, Chen Z, Cramer DW, Cunningham JM, Dagne G, Ebbert-Syfrett J, Fenstermacher D, Fridley BL, Garcia-Closas M, Gayther SA, Ge W, Gentry-Maharaj A, Gonzalez-Bosquet J, Goode EL, Iversen E, Jim H, Kong W, McLaughlin J, Menon U, Monteiro AN, Narod SA, Pharoah PD, Phelan CM, Qu X, Ramus SJ, Risch H, Schildkraut JM, Song H, Stockwell H, Sutphen R, Terry KL, Tyrer J, Vierkant RA, Wentzensen N, Lancaster JM, Cheng JQ, Sellers TA; Ovarian Cancer Association Consortium. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res 2011;71:3896-903. [PMID: 21482675 DOI: 10.1158/0008-5472.CAN-10-4167] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 6.5] [Reference Citation Analysis]
435 Di Fazio P, Maass M, Roth S, Meyer C, Grups J, Rexin P, Bartsch DK, Kirschbaum A. Expression of hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors of the lung. Tumour Biol 2017;39:101042831772841. [DOI: 10.1177/1010428317728417] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
436 Chu H, Cheng C, Chou W, Hu L, Wang H, Hsiung C, Hsu H, Wu P, Hou M, Shen C, Yu J. A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis. Human Molecular Genetics 2014;23:355-67. [DOI: 10.1093/hmg/ddt426] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
437 Yang S, Pei Y, Li X, Zhao S, Zhu M, Zhao A. miR-124 attenuates Japanese encephalitis virus replication by targeting DNM2. Virol J 2016;13:105. [PMID: 27329300 DOI: 10.1186/s12985-016-0562-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
438 Chen XF, Liu Y. MicroRNA-744 inhibited cervical cancer growth and progression through apoptosis induction by regulating Bcl-2. Biomed Pharmacother 2016;81:379-87. [PMID: 27261616 DOI: 10.1016/j.biopha.2016.04.023] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
439 Chen Z, Yu T, Cabay RJ, Jin Y, Mahjabeen I, Luan X, Huang L, Dai Y, Zhou X. miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma. Biomark�Cancer 2017;9:1179299X1700900. [DOI: 10.1177/1179299x1700900001] [Cited by in Crossref: 28] [Article Influence: 7.0] [Reference Citation Analysis]
440 Palmer RD, Murray MJ, Saini HK, van Dongen S, Abreu-Goodger C, Muralidhar B, Pett MR, Thornton CM, Nicholson JC, Enright AJ, Coleman N; Children's Cancer and Leukaemia Group. Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 2010;70:2911-23. [PMID: 20332240 DOI: 10.1158/0008-5472.CAN-09-3301] [Cited by in Crossref: 174] [Cited by in F6Publishing: 90] [Article Influence: 15.8] [Reference Citation Analysis]
441 Shin VY, Jin H, Ng EK, Cheng AS, Chong WW, Wong CY, Leung WK, Sung JJ, Chu KM. NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis. 2011;32:240-245. [PMID: 21081469 DOI: 10.1093/carcin/bgq240] [Cited by in Crossref: 103] [Cited by in F6Publishing: 108] [Article Influence: 9.4] [Reference Citation Analysis]
442 Knight S, Knight T, Khan A, Murphy AJ. Current Management of Pleuropulmonary Blastoma: A Surgical Perspective. Children (Basel) 2019;6:E86. [PMID: 31349569 DOI: 10.3390/children6080086] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
443 Hu R, O'Connell RM. MiR-23b is a safeguard against autoimmunity. Nat Med 2012;18:1009-10. [PMID: 22772548 DOI: 10.1038/nm.2849] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
444 Wang S, Wang L, Zhu T, Gao X, Li J, Wu Y, Zhu H. Improvement of tissue preparation for laser capture microdissection: application for cell type-specific miRNA expression profiling in colorectal tumors. BMC Genomics 2010;11:163. [PMID: 20219115 DOI: 10.1186/1471-2164-11-163] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
445 Naito Y, Sakamoto N, Oue N, Yashiro M, Sentani K, Yanagihara K, Hirakawa K, Yasui W. MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer. Cancer Sci. 2014;105:228-235. [PMID: 24283360 DOI: 10.1111/cas.12329] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 6.7] [Reference Citation Analysis]
446 Takata A, Otsuka M, Yoshikawa T, Kishikawa T, Hikiba Y, Obi S, Goto T, Kang YJ, Maeda S, Yoshida H. MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression. Hepatology. 2013;57:162-170. [PMID: 22898998 DOI: 10.1002/hep.26011] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 9.1] [Reference Citation Analysis]
447 Ghanbari R, Mosakhani N, Asadi J, Nouraee N, Mowla SJ, Yazdani Y, Mohamadkhani A, Poustchi H, Knuutila S, Malekzadeh R. Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma. Iran J Cancer Prev 2015;8:e2329. [PMID: 26413249 DOI: 10.17795/ijcp2329] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 5.2] [Reference Citation Analysis]
448 Nan Y, Han L, Zhang A, Wang G, Jia Z, Yang Y, Yue X, Pu P, Zhong Y, Kang C. MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res. 2010;1359:14-21. [PMID: 20816946 DOI: 10.1016/j.brainres.2010.08.074] [Cited by in Crossref: 121] [Cited by in F6Publishing: 118] [Article Influence: 11.0] [Reference Citation Analysis]
449 Liu F, Liu S, Ai F, Zhang D, Xiao Z, Nie X, Fu Y. miR-107 Promotes Proliferation and Inhibits Apoptosis of Colon Cancer Cells by Targeting Prostate Apoptosis Response-4 (Par4). Oncol Res 2017;25:967-74. [PMID: 27938501 DOI: 10.3727/096504016X14803476672380] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
450 Li JJ, Xi Q, Du WF, Yu RQ, Jiang JH. Label-free fluorescence detection of microRNA based on target induced adenosine2-coralyne-adenosine2 formation. Analyst 2016;141:2384-7. [PMID: 26998900 DOI: 10.1039/c6an00001k] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
451 Telonis AG, Magee R, Loher P, Chervoneva I, Londin E, Rigoutsos I. Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types. Nucleic Acids Res 2017;45:2973-85. [PMID: 28206648 DOI: 10.1093/nar/gkx082] [Cited by in Crossref: 101] [Cited by in F6Publishing: 86] [Article Influence: 25.3] [Reference Citation Analysis]
452 Shi D, Li P, Ma L, Zhong D, Chu H, Yan F, Lv Q, Qin C, Wang W, Wang M, Tong N, Zhang Z, Yin C. A genetic variant in pre-miR-27a is associated with a reduced renal cell cancer risk in a Chinese population. PLoS One 2012;7:e46566. [PMID: 23118855 DOI: 10.1371/journal.pone.0046566] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
453 Zhu HR, Yu XN, Zhang GC, Shi X, Bilegsaikhan E, Guo HY, Liu LL, Cai Y, Song GQ, Liu TT, Dong L, Janssen HLA, Weng SQ, Wu J, Shen XZ, Zhu JM. Comprehensive analysis of long non‑coding RNA‑messenger RNA‑microRNA co‑expression network identifies cell cycle‑related lncRNA in hepatocellular carcinoma. Int J Mol Med 2019;44:1844-54. [PMID: 31485608 DOI: 10.3892/ijmm.2019.4323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
454 Qabaja A, Alshalalfa M, Bismar TA, Alhajj R. Protein network-based Lasso regression model for the construction of disease-miRNA functional interactions. EURASIP J Bioinform Syst Biol 2013;2013:3. [PMID: 23339438 DOI: 10.1186/1687-4153-2013-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
455 Liang H, Gong F, Zhang S, Zhang C, Zen K, Chen X. The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids: Extracellular microRNAs in human body fluids. WIREs RNA 2014;5:285-300. [DOI: 10.1002/wrna.1208] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
456 Dip N, Reis ST, Viana NI, Morais DR, Moura CM, Katz B, Abe DK, Iscaife A, Silva IA, Srougi M, Leite KR. MiRNA in bladder carcinogenesis: A review. World J Clin Urol 2014; 3(3): 238-248 [DOI: 10.5410/wjcu.v3.i3.238] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
457 Wang S, Mo Y, Midorikawa K, Zhang Z, Huang G, Ma N, Zhao W, Hiraku Y, Oikawa S, Murata M. The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L. Oncotarget 2015;6:35893-907. [PMID: 26486082 DOI: 10.18632/oncotarget.5651] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
458 Wang Y, Li M, Zang W, Ma Y, Wang N, Li P, Wang T, Zhao G. MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol 2013;36:385-94. [DOI: 10.1007/s13402-013-0144-6] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
459 Sheng X, Guo Q, Yu J, Xu Y. Experimental research on the effect of microRNA-21 inhibitor on a rat model of intervertebral disc degeneration. Exp Ther Med 2018;16:67-72. [PMID: 29896228 DOI: 10.3892/etm.2018.6156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
460 Zhang N, Shi XM, Guo HQ, Zhao XZ, Zhao WW, Xu JJ, Chen HY. Gold Nanoparticle Couples with Entropy-Driven Toehold-Mediated DNA Strand Displacement Reaction on Magnetic Beads: Toward Ultrasensitive Energy-Transfer-Based Photoelectrochemical Detection of miRNA-141 in Real Blood Sample. Anal Chem 2018;90:11892-8. [PMID: 30229657 DOI: 10.1021/acs.analchem.8b01966] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 19.0] [Reference Citation Analysis]
461 Tan Y, Zhang B, Wu T, Skogerbø G, Zhu X, Guo X, He S, Chen R. Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells. BMC Mol Biol 2009;10:12. [PMID: 19232136 DOI: 10.1186/1471-2199-10-12] [Cited by in Crossref: 130] [Cited by in F6Publishing: 116] [Article Influence: 10.8] [Reference Citation Analysis]
462 Li L, Jia L, Ding Y. Upregulation of miR-375 inhibits human liver cancer cell growth by modulating cell proliferation and apoptosis via targeting ErbB2. Oncol Lett. 2018;16:3319-3326. [PMID: 30127930 DOI: 10.3892/ol.2018.9011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
463 Wang S, Zhao X, Wang J, Wen Y, Zhang L, Wang D, Chen H, Chen Q, Xiang W. Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer. Med Oncol 2013;30. [DOI: 10.1007/s12032-013-0681-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
464 Huang L, Dai T, Lin X, Zhao X, Chen X, Wang C, Li X, Shen H, Wang X. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem Biophys Res Commun 2012;425:127-33. [PMID: 22809510 DOI: 10.1016/j.bbrc.2012.07.025] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 8.4] [Reference Citation Analysis]
465 Shi J, Zhang D, Zhong Z, Zhang W. lncRNA ROR promotes the progression of renal cell carcinoma through the miR‑206/VEGF axis. Mol Med Rep 2019;20:3782-92. [PMID: 31485634 DOI: 10.3892/mmr.2019.10636] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
466 Chen W, Zeng W, Li X, Xiong W, Zhang M, Huang Y, Zhou L, Jiang S. MicroRNA-509-3p increases the sensitivity of epithelial ovarian cancer cells to cisplatin-induced apoptosis. Pharmacogenomics 2016;17:187-97. [PMID: 26786897 DOI: 10.2217/pgs.15.166] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
467 Li M, Ma X, Li M, Zhang B, Huang J, Liu L, Wei Y. Prognostic role of microRNA-210 in various carcinomas: a systematic review and meta-analysis. Dis Markers 2014;2014:106197. [PMID: 24591754 DOI: 10.1155/2014/106197] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
468 Yang Z, Yang D, Zeng K, Li D, Qin L, Cai Y, Jin J. Simultaneous Delivery of antimiR-21 and Doxorubicin by Graphene Oxide for Reducing Toxicity in Cancer Therapy. ACS Omega 2020;5:14437-43. [PMID: 32596581 DOI: 10.1021/acsomega.0c01010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
469 Sachdeva M, Liu Q, Cao J, Lu Z, Mo YY. Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells. Nucleic Acids Res. 2012; Apr 11. [Epub ahead of print]. [PMID: 22495929 DOI: 10.1093/nar/gks324] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
470 Wang N, Zheng J, Chen Z, Liu Y, Dura B, Kwak M, Xavier-Ferrucio J, Lu YC, Zhang M, Roden C, Cheng J, Krause DS, Ding Y, Fan R, Lu J. Single-cell microRNA-mRNA co-sequencing reveals non-genetic heterogeneity and mechanisms of microRNA regulation. Nat Commun 2019;10:95. [PMID: 30626865 DOI: 10.1038/s41467-018-07981-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 27.0] [Reference Citation Analysis]
471 Song N, Li P, Song P, Li Y, Zhou S, Su Q, Li X, Yu Y, Li P, Feng M, Zhang M, Lin W. MicroRNA-138-5p Suppresses Non-small Cell Lung Cancer Cells by Targeting PD-L1/PD-1 to Regulate Tumor Microenvironment. Front Cell Dev Biol 2020;8:540. [PMID: 32754587 DOI: 10.3389/fcell.2020.00540] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
472 Zeng M, Zhu L, Li L, Kang C. miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1. Cell Mol Biol Lett 2017;22:12. [PMID: 28725241 DOI: 10.1186/s11658-017-0041-5] [Cited by in Crossref: 71] [Cited by in F6Publishing: 79] [Article Influence: 17.8] [Reference Citation Analysis]
473 Liu Y, Li M, Zhang G, Pang Z. MicroRNA-10b overexpression promotes non-small cell lung cancer cell proliferation and invasion. Eur J Med Res 2013;18:41. [PMID: 24216130 DOI: 10.1186/2047-783X-18-41] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
474 Cai J, Zhao J, Zhang N, Xu X, Li R, Yi Y, Fang L, Zhang L, Li M, Wu J, Zhang H. MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma. J Biol Chem 2015;290:24678-88. [PMID: 26286747 DOI: 10.1074/jbc.M115.649004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
475 Lee Y, Hyun S, Kim H, Yu J. Amphiphilic Helical Peptides Containing Two Acridine Moieties Display Picomolar Affinity toward HIV-1 RRE and TAR. Angew Chem 2008;120:140-3. [DOI: 10.1002/ange.200703090] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
476 Hong Q, Fang J, Pang Y, Zheng J. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas. Med Oncol 2014;31. [DOI: 10.1007/s12032-014-0037-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
477 Craig MP, Rajakaruna S, Paliy O, Sajjad M, Madhavan S, Reddy N, Zhang J, Bottomley M, Agrawal S, Kadakia MP. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus. Clin Transl Gastroenterol 2020;11:e00125. [PMID: 31934893 DOI: 10.14309/ctg.0000000000000125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
478 Yuan D, Li K, Zhu K, Yan R, Dang C. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer. Cancer Biol Ther. 2015;16:268-275. [PMID: 25629978 DOI: 10.1080/15384047.2014.1002327] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 8.0] [Reference Citation Analysis]
479 Lu J, Song G, Tang Q, Yin J, Zou C, Zhao Z, Xie X, Xu H, Huang G, Wang J, Lee DF, Khokha R, Yang H, Shen J. MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1. Oncogene 2017;36:231-41. [PMID: 27270422 DOI: 10.1038/onc.2016.194] [Cited by in Crossref: 49] [Cited by in F6Publishing: 57] [Article Influence: 9.8] [Reference Citation Analysis]
480 Zhao Y, Xie P, Fan H. Genomic profiling of microRNAs and proteomics reveals an early molecular alteration associated with tumorigenesis induced by MC-LR in mice. Environ Sci Technol 2012;46:34-41. [PMID: 21882851 DOI: 10.1021/es201514h] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
481 Wang Y, Tian K, Du X, Shi RC, Gu LQ. Remote Activation of a Nanopore for High-Performance Genetic Detection Using a pH Taxis-Mimicking Mechanism. Anal Chem 2017;89:13039-43. [PMID: 29183111 DOI: 10.1021/acs.analchem.7b03979] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
482 Zhang P, Fu H, Du S, Wang F, Yang J, Cai W, Liu D. Click RNA for Rapid Capture and Identification of Intracellular MicroRNA Targets. Anal Chem 2019;91:15740-7. [PMID: 31714070 DOI: 10.1021/acs.analchem.9b03943] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
483 Li X, Wang L, Yu J, Xu J, Du J. The genetic association between pri-miR-34b/c polymorphism (rs4938723 T > C) and susceptibility to cancers: evidence from published studies. Tumor Biol 2014;35:12525-34. [DOI: 10.1007/s13277-014-2572-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
484 Al-Qahtani AA, Al-Anazi MR, Nazir N, Wani K, Abdo AA, Sanai FM, Khan MQ, Al-Ashgar HI, Albenmousa A, Al-Hamoudi WK, Alswat KA, Al-Ahdal MN. Association of single nucleotide polymorphisms in microRNAs with susceptibility to hepatitis B virus infection and HBV-related liver complications: A study in a Saudi Arabian population. J Viral Hepat 2017;24:1132-42. [PMID: 28685993 DOI: 10.1111/jvh.12749] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
485 Sellitto A, Pecoraro G, Giurato G, Nassa G, Rizzo F, Saggese P, Martinez CA, Scafoglio C, Tarallo R. Regulation of Metabolic Reprogramming by Long Non-Coding RNAs in Cancer. Cancers (Basel) 2021;13:3485. [PMID: 34298698 DOI: 10.3390/cancers13143485] [Reference Citation Analysis]
486 Heery R, Finn SP, Cuffe S, Gray SG. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells. Cancers (Basel). 2017;9. [PMID: 28430163 DOI: 10.3390/cancers9040038] [Cited by in Crossref: 88] [Cited by in F6Publishing: 96] [Article Influence: 22.0] [Reference Citation Analysis]
487 Wang YW, Chen X, Gao JW, Zhang H, Ma RR, Gao ZH, Gao P. High expression of cAMP-responsive element-binding protein 1 (CREB1) is associated with metastasis, tumor stage and poor outcome in gastric cancer. Oncotarget 2015;6:10646-57. [PMID: 25825983 DOI: 10.18632/oncotarget.3392] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
488 Tili E, Michaille JJ, Gandhi V, Plunkett W, Sampath D, Calin GA. miRNAs and their potential for use against cancer and other diseases. Future Oncol 2007;3:521-37. [PMID: 17927518 DOI: 10.2217/14796694.3.5.521] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 6.3] [Reference Citation Analysis]
489 Jang JS, Simon VA, Feddersen RM, Rakhshan F, Schultz DA, Zschunke MA, Lingle WL, Kolbert CP, Jen J. Quantitative miRNA expression analysis using fluidigm microfluidics dynamic arrays. BMC Genomics 2011;12:144. [PMID: 21388556 DOI: 10.1186/1471-2164-12-144] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 8.7] [Reference Citation Analysis]
490 Goto T, Fujiya M, Konishi H, Sasajima J, Fujibayashi S, Hayashi A, Utsumi T, Sato H, Iwama T, Ijiri M, Sakatani A, Tanaka K, Nomura Y, Ueno N, Kashima S, Moriichi K, Mizukami Y, Kohgo Y, Okumura T. An elevated expression of serum exosomal microRNA-191, - 21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker. BMC Cancer. 2018;18:116. [PMID: 29385987 DOI: 10.1186/s12885-018-4006-5] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 26.0] [Reference Citation Analysis]
491 Laganà AS, Vitale SG, Sapia F, Valenti G, Corrado F, Padula F, Rapisarda AMC, D’anna R. miRNA expression for early diagnosis of preeclampsia onset: hope or hype? The Journal of Maternal-Fetal & Neonatal Medicine 2017;31:817-21. [DOI: 10.1080/14767058.2017.1296426] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 14.5] [Reference Citation Analysis]
492 Liu H. MicroRNAs in breast cancer initiation and progression. Cell Mol Life Sci 2012;69:3587-99. [PMID: 22926415 DOI: 10.1007/s00018-012-1128-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
493 Ferragut Cardoso AP, Udoh KT, States JC. Arsenic-induced changes in miRNA expression in cancer and other diseases. Toxicol Appl Pharmacol 2020;409:115306. [PMID: 33127375 DOI: 10.1016/j.taap.2020.115306] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
494 Aparicio LA, Abella V, Valladares M, Figueroa A. Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition. Cell Mol Life Sci 2013;70:4463-77. [PMID: 23715860 DOI: 10.1007/s00018-013-1379-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
495 Kuo Y, Tai Y, Lo H, Chen Y, Cheng H, Fang W, Lin S, Yang C, Tsai S, Wu L. MiR-99a exerts anti-metastasis through inhibiting myotubularin-related protein 3 expression in oral cancer. Oral Dis 2014;20:e65-75. [DOI: 10.1111/odi.12133] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
496 Arabipour I, Amani J, Mirhosseini SA, Salimian J. The study of genes and signal transduction pathways involved in mustard lung injury: A gene therapy approach. Gene 2019;714:143968. [PMID: 31323308 DOI: 10.1016/j.gene.2019.143968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
497 Osawa S, Shimada Y, Sekine S, Okumura T, Nagata T, Fukuoka J, Tsukada K. MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples. Oncol Lett 2011;2:613-9. [PMID: 22848236 DOI: 10.3892/ol.2011.313] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
498 Schmitz U, Wolkenhauer O. Web resources for microRNA research. Adv Exp Med Biol 2013;774:225-50. [PMID: 23377976 DOI: 10.1007/978-94-007-5590-1_12] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
499 Zhang H. The Inhibitory Effect of Apolipoprotein B mRNA-Editing Enzyme Catalytic Polypeptide-Like 3G (APOBEC3G) and Its Family Members on the Activity of Cellular MicroRNAs. In: Rhoads RE, editor. miRNA Regulation of the Translational Machinery. Berlin: Springer Berlin Heidelberg; 2010. pp. 71-83. [DOI: 10.1007/978-3-642-03103-8_5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
500 Lai JKH, Gagalova KK, Kuenne C, El-Brolosy MA, Stainier DYR. Induction of interferon-stimulated genes and cellular stress pathways by morpholinos in zebrafish. Dev Biol 2019;454:21-8. [PMID: 31201802 DOI: 10.1016/j.ydbio.2019.06.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
501 Chang C, Shi H, Wang C, Wang J, Geng N, Jiang X, Wang X. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma. Neurosci Lett. 2012;531:204-208. [PMID: 23103713 DOI: 10.1016/j.neulet.2012.10.021] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
502 Alsaweed M, Hepworth AR, Lefèvre C, Hartmann PE, Geddes DT, Hassiotou F. Human Milk MicroRNA and Total RNA Differ Depending on Milk Fractionation. J Cell Biochem 2015;116:2397-407. [PMID: 25925799 DOI: 10.1002/jcb.25207] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
503 Xu F, Luo L, Shi H, He X, Lei Y, Tang J, He D, Qiao Z, Wang K. Label-free and sensitive microRNA detection based on a target recycling amplification-integrated superlong poly(thymine)-hosted copper nanoparticle strategy. Anal Chim Acta 2018;1010:54-61. [PMID: 29447671 DOI: 10.1016/j.aca.2018.01.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
504 Lv XB, Zhang X, Deng L, Jiang L, Meng W, Lu Z, Wang X. MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting Bim. Cell Biol Int 2014;38:435-43. [PMID: 24375836 DOI: 10.1002/cbin.10225] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
505 Herceg Z, Hainaut P. Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Mol Oncol 2007;1:26-41. [PMID: 19383285 DOI: 10.1016/j.molonc.2007.01.004] [Cited by in Crossref: 107] [Cited by in F6Publishing: 94] [Article Influence: 7.6] [Reference Citation Analysis]
506 Zhang G, Wang Q, Xu R. Therapeutics Based on microRNA: A New Approach for Liver Cancer. Curr Genomics 2010;11:311-25. [PMID: 21286309 DOI: 10.2174/138920210791616671] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
507 Casey MC, Prakash A, Holian E, McGuire A, Kalinina O, Shalaby A, Curran C, Webber M, Callagy G, Bourke E, Kerin MJ, Brown JA. Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer. BMC Cancer 2019;19:712. [PMID: 31324173 DOI: 10.1186/s12885-019-5884-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
508 Sonkoly E, Pivarcsi A. MicroRNAs in inflammation and response to injuries induced by environmental pollution. Mutat Res 2011;717:46-53. [PMID: 21329708 DOI: 10.1016/j.mrfmmm.2011.02.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
509 Yu S, Kim J, Min H, Yoon S. Ensemble learning can significantly improve human microRNA target prediction. Methods 2014;69:220-9. [PMID: 25088780 DOI: 10.1016/j.ymeth.2014.07.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
510 Sliva K, Schnierle BS. Selective gene silencing by viral delivery of short hairpin RNA. Virol J 2010;7:248. [PMID: 20858246 DOI: 10.1186/1743-422X-7-248] [Cited by in Crossref: 66] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
511 Zheng LF, Sun WY. Meta-analysis of microRNAs as biomarkers for muscle-invasive bladder cancer. Biomed Rep 2016;5:159-64. [PMID: 27446534 DOI: 10.3892/br.2016.705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
512 Chen S, Chen X, Sun KX, Xiu YL, Liu BL, Feng MX, Sang XB, Zhao Y. MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells. PLoS One 2016;11:e0165776. [PMID: 27829043 DOI: 10.1371/journal.pone.0165776] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
513 Greenberg E, Hershkovitz L, Itzhaki O, Hajdu S, Nemlich Y, Ortenberg R, Gefen N, Edry L, Modai S, Keisari Y, Besser MJ, Schachter J, Shomron N, Markel G. Regulation of cancer aggressive features in melanoma cells by microRNAs. PLoS One 2011;6:e18936. [PMID: 21541354 DOI: 10.1371/journal.pone.0018936] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 6.2] [Reference Citation Analysis]
514 Zhou Q, Han LR, Zhou YX, Li Y. MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3. Int J Gynecol Cancer 2016;26:817-24. [PMID: 27206216 DOI: 10.1097/IGC.0000000000000686] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 9.8] [Reference Citation Analysis]
515 Sannigrahi MK, Sharma R, Panda NK, Khullar M. Role of non-coding RNAs in head and neck squamous cell carcinoma: A narrative review. Oral Dis 2018;24:1417-27. [PMID: 28941018 DOI: 10.1111/odi.12782] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
516 Jiang M, Li X, Quan X, Li X, Zhou B. Clinically Correlated MicroRNAs in the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Biomed Res Int 2018;2018:5930951. [PMID: 30050938 DOI: 10.1155/2018/5930951] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
517 Noruzi S, Azizian M, Mohammadi R, Hosseini SA, Rashidi B, Mohamadi Y, Nesaei A, Seiri P, Sahebkar A, Salarinia R, Aghdam AM, Mirzaei H. Micro-RNAs as critical regulators of matrix metalloproteinases in cancer. J Cell Biochem 2018;119:8694-712. [PMID: 30132957 DOI: 10.1002/jcb.27182] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
518 Liu L, Wang D, Qiu Y, Dong H, Zhan X. Overexpression of microRNA-15 increases the chemosensitivity of colon cancer cells to 5-fluorouracil and oxaliplatin by inhibiting the nuclear factor-κB signalling pathway and inducing apoptosis. Exp Ther Med 2018;15:2655-60. [PMID: 29467857 DOI: 10.3892/etm.2017.5675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
519 Tian C, Huang D, Yu Y, Zhang J, Fang Q, Xie C. ABCG1 as a potential oncogene in lung cancer. Exp Ther Med 2017;13:3189-94. [PMID: 28588672 DOI: 10.3892/etm.2017.4393] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
520 Mueller S, Dennison G, Liu S. An Assessment on Ethanol-Blended Gasoline/Diesel Fuels on Cancer Risk and Mortality. Int J Environ Res Public Health 2021;18:6930. [PMID: 34203568 DOI: 10.3390/ijerph18136930] [Reference Citation Analysis]
521 Theophilou G, Paraskevaidi M, Lima KM, Kyrgiou M, Martin-hirsch PL, Martin FL. Extracting biomarkers of commitment to cancer development: potential role of vibrational spectroscopy in systems biology. Expert Review of Molecular Diagnostics 2015;15:693-713. [DOI: 10.1586/14737159.2015.1028372] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
522 Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, Brant SR, Chakravarti S, Kwon JH. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology. 2008;135:1624-1635.e24. [PMID: 18835392 DOI: 10.1053/j.gastro.2008.07.068] [Cited by in Crossref: 317] [Cited by in F6Publishing: 353] [Article Influence: 24.4] [Reference Citation Analysis]
523 Lu Z, Duan D, Cao R, Zhang L, Zheng K, Li J. A reverse transcription-free real-time PCR assay for rapid miRNAs quantification based on effects of base stacking. Chem Commun (Camb) 2011;47:7452-4. [PMID: 21597629 DOI: 10.1039/c1cc10442j] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
524 Yao Y, Zhang H, Tian T, Liu Y, Zhu R, Ji J, Liu B. Iodide-modified Ag nanoparticles coupled with DSN-Assisted cycling amplification for label-free and ultrasensitive SERS detection of MicroRNA-21. Talanta 2021;235:122728. [PMID: 34517596 DOI: 10.1016/j.talanta.2021.122728] [Reference Citation Analysis]
525 Suyundikov A, Stevens JR, Corcoran C, Herrick J, Wolff RK, Slattery ML. Accounting for dependence induced by weighted KNN imputation in paired samples, motivated by a colorectal cancer study. PLoS One 2015;10:e0119876. [PMID: 25849489 DOI: 10.1371/journal.pone.0119876] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
526 Luo H, Zou J, Dong Z, Zeng Q, Wu D, Liu L. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma. Biochemical Journal 2012;442:311-21. [DOI: 10.1042/bj20111517] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
527 Spizzo R, Rushworth D, Guerrero M, Calin GA. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment. Clin Lymphoma Myeloma 2009;9 Suppl 3:S313-8. [PMID: 19778859 DOI: 10.3816/CLM.2009.s.030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
528 Yang Y, Ding L, Hu Q, Xia J, Sun J, Wang X, Xiong H, Gurbani D, Li L, Liu Y, Liu A. MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis. Mol Cancer 2017;16:141. [PMID: 28830450 DOI: 10.1186/s12943-017-0710-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 67] [Article Influence: 14.0] [Reference Citation Analysis]
529 Zhu Z, Gao W, Qian Z, Miao Y. Genetic variation of miRNA sequence in pancreatic cancer. Acta Biochim Biophys Sin (Shanghai) 2009;41:407-13. [PMID: 19430705 DOI: 10.1093/abbs/gmp023] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
530 Zheng J, Ge P, Liu X, Wei J, Wu G, Li X. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10. Tumour Biol 2017;39:1010428317706207. [PMID: 28656883 DOI: 10.1177/1010428317706207] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
531 Tsai CH, Lin LT, Wang CY, Chiu YW, Chou YT, Chiu SJ, Wang HE, Liu RS, Wu CY, Chan PC, Yang MH, Chiou SH, Liao MJ, Lee YJ. Over-expression of cofilin-1 suppressed growth and invasion of cancer cells is associated with up-regulation of let-7 microRNA. Biochim Biophys Acta 2015;1852:851-61. [PMID: 25597880 DOI: 10.1016/j.bbadis.2015.01.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
532 Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L, Solway J, Gern JE, Lemanske RF, Nicolae D. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet. 2007;81:829-834. [PMID: 17847008 DOI: 10.1086/521200] [Cited by in Crossref: 270] [Cited by in F6Publishing: 271] [Article Influence: 19.3] [Reference Citation Analysis]
533 Zhao WY, Wang Y, An ZJ, Shi CG, Zhu GA, Wang B, Lu MY, Pan CK, Chen P. Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer. Biochem Biophys Res Commun 2013;435:466-71. [PMID: 23673296 DOI: 10.1016/j.bbrc.2013.05.010] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 8.1] [Reference Citation Analysis]
534 Araújo R, Santos JMO, Fernandes M, Dias F, Sousa H, Ribeiro J, Bastos MMSM, Oliveira PA, Carmo D, Casaca F, Silva S, Medeiros R, Gil da Costa RM. Expression profile of microRNA-146a along HPV-induced multistep carcinogenesis: a study in HPV16 transgenic mice. J Cancer Res Clin Oncol 2018;144:241-8. [DOI: 10.1007/s00432-017-2549-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
535 Hao N, Li X, Zhang H, Xu J, Chen H. A highly sensitive ratiometric electrochemiluminescent biosensor for microRNA detection based on cyclic enzyme amplification and resonance energy transfer. Chem Commun 2014;50:14828-30. [DOI: 10.1039/c4cc06801g] [Cited by in Crossref: 79] [Cited by in F6Publishing: 9] [Article Influence: 11.3] [Reference Citation Analysis]
536 Ma F, Zhang M, Gong W, Weng M, Quan Z. MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma. PLoS One. 2015;10:e0126499. [PMID: 25962180 DOI: 10.1371/journal.pone.0126499] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
537 Schmidt LH, Spieker T, Koschmieder S, Schäffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D, Marra A, Hillejan L, Wiebe K, Berdel WE, Wiewrodt R, Muller-Tidow C. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol 2011;6:1984-92. [PMID: 22088988 DOI: 10.1097/JTO.0b013e3182307eac] [Cited by in Crossref: 357] [Cited by in F6Publishing: 256] [Article Influence: 39.7] [Reference Citation Analysis]
538 de Antonellis P, Liguori L, Falanga A, Carotenuto M, Ferrucci V, Andolfo I, Marinaro F, Scognamiglio I, Virgilio A, De Rosa G, Galeone A, Galdiero S, Zollo M. MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines. Naunyn-Schmiedeberg's Arch Pharmacol 2013;386:287-302. [DOI: 10.1007/s00210-013-0837-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
539 Kang J, Zhang C, Zhi Z, Wang Y, Liu J, Wu F, Xu G. Stem-like cells of various origins showed therapeutic effect to improve the recovery of spinal cord injury. Artif Cells Nanomed Biotechnol 2020;48:627-38. [PMID: 32054316 DOI: 10.1080/21691401.2020.1725031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
540 Vincent K, Pichler M, Lee GW, Ling H. MicroRNAs, genomic instability and cancer. Int J Mol Sci. 2014;15:14475-14491. [PMID: 25141103 DOI: 10.3390/ijms150814475] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
541 Nangia-Makker P, Yu Y, Vasudevan A, Farhana L, Rajendra SG, Levi E, Majumdar AP. Metformin: a potential therapeutic agent for recurrent colon cancer. PLoS One. 2014;9:e84369. [PMID: 24465408 DOI: 10.1371/journal.pone.0084369] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 10.6] [Reference Citation Analysis]
542 Huang M, Huang R, Yue H, Shan Y, Xing D. Ultrasensitive and high-specific microRNA detection using hyper-branching rolling circle amplified CRISPR/Cas13a biosensor. Sensors and Actuators B: Chemical 2020;325:128799. [DOI: 10.1016/j.snb.2020.128799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
543 Shao N, Wang L, Xue L, Wang R, Lan Q. Plasma miR-454-3p as a potential prognostic indicator in human glioma. Neurol Sci 2015;36:309-13. [PMID: 25190548 DOI: 10.1007/s10072-014-1938-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
544 Tripputi P, Bianchi P, Fermo E, Bignotto M, Zanella A. Chromosome 7q31.1 deletion in myeloid neoplasms. Hum Pathol 2014;45:368-71. [PMID: 24439223 DOI: 10.1016/j.humpath.2013.09.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
545 Sun XF, Sun JP, Hou HT, Li K, Liu X, Ge QX. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma. Tumour Biol 2016;37:15325-32. [PMID: 27704356 DOI: 10.1007/s13277-016-5444-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
546 Ajdarkosh H, Dadpay M, Yahaghi E, Pirzaman ER, Fayyaz AF, Darian EK, Mokarizadeh A. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Diagn Pathol 2015;10:135. [PMID: 26248880 DOI: 10.1186/s13000-015-0371-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
547 Song C, Wang G, Kong D. A facile fluorescence method for versatile biomolecular detection based on pristine α-Fe 2 O 3 nanoparticle-induced fluorescence quenching. Biosensors and Bioelectronics 2015;68:239-44. [DOI: 10.1016/j.bios.2015.01.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
548 Boni V, Zarate R, Villa JC, Bandrés E, Gomez MA, Maiello E, Garcia-Foncillas J, Aranda E. Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. Pharmacogenomics J. 2011;11:429-436. [PMID: 20585341 DOI: 10.1038/tpj.2010.58] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 6.5] [Reference Citation Analysis]
549 Akisawa T, Yamada K, Nagatsugi F. Synthesis of peptide nucleic acids (PNA) with a crosslinking agent to RNA and effective inhibition of dicer. Bioorg Med Chem Lett 2016;26:5902-6. [PMID: 27838183 DOI: 10.1016/j.bmcl.2016.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
550 Alpini G, Glaser SS, Zhang JP, Francis H, Han Y, Gong J, Stokes A, Francis T, Hughart N, Hubble L. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol. 2011;55:1339-1345. [PMID: 21703189 DOI: 10.1016/j.jhep.2011.04.015] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 9.6] [Reference Citation Analysis]
551 Guo LH, Li H, Wang F, Yu J, He JS. The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer. Int J Mol Sci. 2013;14:14171-14184. [PMID: 23880861 DOI: 10.3390/ijms140714171] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 8.4] [Reference Citation Analysis]
552 Ge YZ, Xin H, Lu TZ, Xu Z, Yu P, Zhao YC, Li MH, Zhao Y, Zhong B, Xu X. MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma. Sci Rep. 2015;5:10328. [PMID: 25981392 DOI: 10.1038/srep10328] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
553 Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis 2012;33:1113-20. [PMID: 22362728 DOI: 10.1093/carcin/bgs113] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 17.0] [Reference Citation Analysis]
554 Granados-Riveron JT, Aquino-Jarquin G. CRISPR/Cas13-Based Approaches for Ultrasensitive and Specific Detection of microRNAs. Cells 2021;10:1655. [PMID: 34359825 DOI: 10.3390/cells10071655] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
555 Tavano F, di Mola FF, Piepoli A, Panza A, Copetti M, Burbaci FP, Latiano T, Pellegrini F, Maiello E, Andriulli A. Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers. Pancreas. 2012;41:1280-1284. [PMID: 22836856 DOI: 10.1097/mpa.0b013e31824c11f4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
556 Zheng S, Li R, Liang J, Wen Z, Huang X, Du X, Dong S, Zhu K, Chen X, Liu D, Wu J, Liu Y, Zou X, Wang Y, Li J, Zeng F, Feng L, Yang G, Jing C. Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma. Genetic Testing and Molecular Biomarkers 2020;24:188-94. [DOI: 10.1089/gtmb.2019.0147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
557 Yu H, Song H, Liu L, Hu S, Liao Y, Li G, Xiao X, Chen X, He S. MiR-92a modulates proliferation, apoptosis, migration, and invasion of osteosarcoma cell lines by targeting Dickkopf-related protein 3. Biosci Rep 2019;39:BSR20190410. [PMID: 30926679 DOI: 10.1042/BSR20190410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
558 Huang YC, Lee CT, Lee JC, Liu YW, Chen YJ, Tseng JT, Kang JW, Sheu BS, Lin BW, Hung LY. Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition. Oncotarget 2016;7:76852-66. [PMID: 27764771 DOI: 10.18632/oncotarget.12719] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
559 Cui M, Li X, Xu J, Chen H. Target-triggered, self-powered DNAzyme–MnO 2 nanosystem: towards imaging microRNAs in living cells. Chem Commun 2019;55:13366-9. [DOI: 10.1039/c9cc06623c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
560 Chan WC, Lin WC. MetaMirClust: Discovery and Exploration of Evolutionarily Conserved miRNA Clusters. Methods Mol Biol 2016;1375:75-89. [PMID: 25861770 DOI: 10.1007/7651_2015_237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
561 Hawa Z, Haque I, Ghosh A, Banerjee S, Harris L, Banerjee SK. The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression. Int J Mol Sci 2016;17:E809. [PMID: 27240340 DOI: 10.3390/ijms17060809] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
562 Jia HL, Zhou DS. Downregulation of microRNA-367 promotes osteoblasts growth and proliferation of mice during fracture by activating the PANX3-mediated Wnt/β-catenin pathway. J Cell Biochem 2018. [PMID: 30556206 DOI: 10.1002/jcb.28108] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
563 Martin SL, Royston KJ, Tollefsbol TO. The Role of Non-Coding RNAs and Isothiocyanates in Cancer. Mol Nutr Food Res 2018;62:e1700913. [PMID: 29532604 DOI: 10.1002/mnfr.201700913] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
564 Gu Y, Liu S, Zhang X, Chen G, Liang H, Yu M, Liao Z, Zhou Y, Zhang CY, Wang T, Wang C, Zhang J, Chen X. Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer. Protein Cell 2017;8:455-66. [PMID: 28364280 DOI: 10.1007/s13238-017-0393-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
565 Gailhouste L, Gomez-Santos L, Hagiwara K, Hatada I, Kitagawa N, Kawaharada K, Thirion M, Kosaka N, Takahashi RU, Shibata T. miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells. Hepatology. 2013;58:1153-1165. [PMID: 23532995 DOI: 10.1002/hep.26422] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 11.9] [Reference Citation Analysis]
566 Palmieri D, D'angelo D, Valentino T, De Martino I, Ferraro A, Wierinckx A, Fedele M, Trouillas J, Fusco A. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis. Oncogene 2012;31:3857-65. [DOI: 10.1038/onc.2011.557] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
567 Krell J, Frampton AE, Stebbing J. The clinical significance of tumor infiltrating lymphoctyes in breast cancer: does subtype matter? BMC Cancer 2012;12:135. [PMID: 22471994 DOI: 10.1186/1471-2407-12-135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
568 Yan J, Ying S, Cai X. MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma. Biomed Res Int 2018;2018:2754941. [PMID: 29651425 DOI: 10.1155/2018/2754941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
569 Zhi F, Chen X, Wang S, Xia X, Shi Y, Guan W, Shao N, Qu H, Yang C, Zhang Y. The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur J Cancer. 2010;46:1640-1649. [PMID: 20219352 DOI: 10.1016/j.ejca.2010.02.003] [Cited by in Crossref: 110] [Cited by in F6Publishing: 105] [Article Influence: 10.0] [Reference Citation Analysis]
570 Han ZB, Chen HY, Fan JW, Wu JY, Tang HM, Peng ZH. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation. J Cancer Res Clin Oncol. 2012;138:153-161. [PMID: 22071603 DOI: 10.1007/s00432-011-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
571 Wu C, Peng M, Yeh K, Tsai Y, Chiang C, Cheng Y. Inactivation of p53 in pterygium influence miR-200a expression resulting in ZEB1/ZEB2 up-regulation and EMT processing. Experimental Eye Research 2016;146:206-11. [DOI: 10.1016/j.exer.2016.03.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
572 Vanacore D, Boccellino M, Rossetti S, Cavaliere C, D'Aniello C, Di Franco R, Romano FJ, Montanari M, La Mantia E, Piscitelli R, Nocerino F, Cappuccio F, Grimaldi G, Izzo A, Castaldo L, Pepe MF, Malzone MG, Iovane G, Ametrano G, Stiuso P, Quagliuolo L, Barberio D, Perdonà S, Muto P, Montella M, Maiolino P, Veneziani BM, Botti G, Caraglia M, Facchini G. Micrornas in prostate cancer: an overview. Oncotarget 2017;8:50240-51. [PMID: 28445135 DOI: 10.18632/oncotarget.16933] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 19.3] [Reference Citation Analysis]
573 Xu P, Wang L, Huang L, Li W, Lv S, Lv M, Ma J, Zhou Q, Wu X, Fu Z, Lu C, Yin H. Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology. Biomed Pharmacother 2015;75:173-8. [PMID: 26293775 DOI: 10.1016/j.biopha.2015.07.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
574 Jung E, Seong Y, Jeon B, Kwon Y, Song H. MicroRNAs of miR-17-92 cluster increase gene expression by targeting mRNA-destabilization pathways. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2018;1861:603-12. [DOI: 10.1016/j.bbagrm.2018.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
575 Negrini M, Nicoloso MS, Calin GA. MicroRNAs and cancer--new paradigms in molecular oncology. Curr Opin Cell Biol. 2009;21:470-479. [PMID: 19411171 DOI: 10.1016/j.ceb.2009.03.002] [Cited by in Crossref: 159] [Cited by in F6Publishing: 160] [Article Influence: 13.3] [Reference Citation Analysis]
576 Zangouei AS, Moghbeli M. MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells. Genes Environ 2021;43:21. [PMID: 34099061 DOI: 10.1186/s41021-021-00192-4] [Reference Citation Analysis]
577 Rinnerthaler G, Hackl H, Gampenrieder SP, Hamacher F, Hufnagl C, Hauser-Kronberger C, Zehentmayr F, Fastner G, Sedlmayer F, Mlineritsch B, Greil R. miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites. Int J Mol Sci 2016;17:E156. [PMID: 26821018 DOI: 10.3390/ijms17020156] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
578 Cortés-Sempere M, Ibáñez de Cáceres I. microRNAs as novel epigenetic biomarkers for human cancer. Clin Transl Oncol 2011;13:357-62. [PMID: 21680295 DOI: 10.1007/s12094-011-0668-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
579 Wang X, Huang S, Chen JL. Understanding of leukemic stem cells and their clinical implications. Mol Cancer 2017;16:2. [PMID: 28137304 DOI: 10.1186/s12943-016-0574-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
580 Xiang S, Zeng H, Xia F, Ji Q, Xue J, Ren R, Que F, Zhou B. The dietary flavonoid isoliquiritigenin induced apoptosis and suppressed metastasis in melanoma cells: An in vitro and in vivo study. Life Sci 2021;264:118598. [PMID: 33189818 DOI: 10.1016/j.lfs.2020.118598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
581 Sengupta JN, Pochiraju S, Kannampalli P, Bruckert M, Addya S, Yadav P, Miranda A, Shaker R, Banerjee B. MicroRNA-mediated GABA Aα-1 receptor subunit down-regulation in adult spinal cord following neonatal cystitis-induced chronic visceral pain in rats. Pain 2013;154:59-70. [PMID: 23273104 DOI: 10.1016/j.pain.2012.09.002] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 7.6] [Reference Citation Analysis]
582 Pacifici M, Delbue S, Kadri F, Peruzzi F. Cerebrospinal fluid MicroRNA profiling using quantitative real time PCR. J Vis Exp 2014;:e51172. [PMID: 24514260 DOI: 10.3791/51172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
583 Offman J, Fitzgerald RC. Alternatives to Traditional Per-Oral Endoscopy for Screening. Gastrointest Endosc Clin N Am 2017;27:379-96. [PMID: 28577763 DOI: 10.1016/j.giec.2017.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
584 Yue X, Zhao Y, Zhang C, Li J, Liu Z, Liu J, Hu W. Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction. Oncotarget 2016;7:3777-90. [PMID: 26716902 DOI: 10.18632/oncotarget.6756] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
585 Ma C, Zhang W, Wu Q, Liu Y, Wang C, Lao G, Yang L, Liu P. Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma. PLoS One 2018;13:e0193625. [PMID: 29513728 DOI: 10.1371/journal.pone.0193625] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
586 Smirnova L, Sittka A, Luch A. On the role of low-dose effects and epigenetics in toxicology. Exp Suppl 2012;101:499-550. [PMID: 22945581 DOI: 10.1007/978-3-7643-8340-4_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
587 Li Y, Zhang Z. Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis. Sci Rep. 2014;4:7097. [PMID: 25403569 DOI: 10.1038/srep07097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
588 Bi C, Zhang Y, Li B, Guo M, Fu Y. MicroRNA‐520a‐3p suppresses epithelial–mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1 ‐mediated JAK/STAT signaling pathway. J Cell Physiol 2019;234:4054-67. [DOI: 10.1002/jcp.27199] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 7.7] [Reference Citation Analysis]
589 Deng S, Zhao Q, Zhen L, Zhang C, Liu C, Wang G, Zhang L, Bao L, Lu Y, Meng L, Lü J, Yu P, Lin X, Zhang Y, Chen YH, Fan H, Cho WC, Liu Z, Yu Z. Neonatal Heart-Enriched miR-708 Promotes Proliferation and Stress Resistance of Cardiomyocytes in Rodents. Theranostics 2017;7:1953-65. [PMID: 28638481 DOI: 10.7150/thno.16478] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
590 Ghuwalewala S, Ghatak D, Das S, Roy S, Das P, Butti R, Gorain M, Nath S, Kundu GC, Roychoudhury S. MiRNA-146a/AKT/β-Catenin Activation Regulates Cancer Stem Cell Phenotype in Oral Squamous Cell Carcinoma by Targeting CD24. Front Oncol 2021;11:651692. [PMID: 34712602 DOI: 10.3389/fonc.2021.651692] [Reference Citation Analysis]
591 Wong KY, Yu L, Chim CS. DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family. Epigenomics 2011;3:83-92. [PMID: 22126155 DOI: 10.2217/epi.10.74] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 6.2] [Reference Citation Analysis]
592 Hojo N, Tatsumi N, Moriguchi N, Matsumura A, Morimoto S, Nakata J, Fujiki F, Nishida S, Nakajima H, Tsuboi A, Oka Y, Hosen N, Hayashi S, Sugiyama H, Oji Y. A Zbtb7a proto-oncogene as a novel target for miR-125a. Mol Carcinog 2016;55:2001-9. [PMID: 26713860 DOI: 10.1002/mc.22446] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
593 Zhang C, Shu L, Kong AN. MicroRNAs: New players in cancer prevention targeting Nrf2, oxidative stress and inflammatory pathways. Curr Pharmacol Rep 2015;1:21-30. [PMID: 26618104 DOI: 10.1007/s40495-014-0013-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
594 Liu L, Zhou W, Cheng CT, Ren X, Somlo G, Fong MY, Chin AR, Li H, Yu Y, Xu Y, O'Connor ST, O'Connor TR, Ann DK, Stark JM, Wang SE. TGFβ induces "BRCAness" and sensitivity to PARP inhibition in breast cancer by regulating DNA-repair genes. Mol Cancer Res 2014;12:1597-609. [PMID: 25103497 DOI: 10.1158/1541-7786.MCR-14-0201] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
595 Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, Berger U. LNA-mediated microRNA silencing in non-human primates. Nature. 2008;452:896-899. [PMID: 18368051 DOI: 10.1038/nature06783] [Cited by in Crossref: 1198] [Cited by in F6Publishing: 1145] [Article Influence: 92.2] [Reference Citation Analysis]
596 Wang J, Wang C, Li Q, Guo C, Sun W, Zhao D, Jiang S, Hao L, Tian Y, Liu S, Sun MZ. miR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/ERK/MMP2/MMP9 pathway. Biomed Pharmacother 2020;127:110215. [PMID: 32413671 DOI: 10.1016/j.biopha.2020.110215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
597 Matei D, Nephew KP. Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes. Cancer Res 2020;80:3775-85. [PMID: 32381656 DOI: 10.1158/0008-5472.CAN-19-3837] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
598 Ding Y, Gu XY, Xu F, Shi XY, Yang DZ, Zhong J, Wang SM. MicroRNA expression profiling of mature ovarian teratomas. Oncol Lett 2012;3:35-8. [PMID: 22740852 DOI: 10.3892/ol.2011.438] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
599 Zhang J, Song Y, Zhang C, Zhi X, Fu H, Ma Y, Chen Y, Pan F, Wang K, Ni J. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer. Theranostics. 2015;5:733-745. [PMID: 25897338 DOI: 10.7150/thno.10305] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 15.0] [Reference Citation Analysis]
600 Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008;299:425-436. [PMID: 18230780 DOI: 10.1001/jama.299.4.425] [Cited by in Crossref: 905] [Cited by in F6Publishing: 1029] [Article Influence: 69.6] [Reference Citation Analysis]
601 Mansour MR, Sanda T, Lawton LN, Li X, Kreslavsky T, Novina CD, Brand M, Gutierrez A, Kelliher MA, Jamieson CH, von Boehmer H, Young RA, Look AT. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. J Exp Med 2013;210:1545-57. [PMID: 23857984 DOI: 10.1084/jem.20122516] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 9.9] [Reference Citation Analysis]
602 Banerjee CM. Dr. K.C. Chaudhuri--reminiscences. Indian J Pediatr. 1974;41:89-90. [PMID: 4609421 DOI: 10.1155/2015/921435] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 0.6] [Reference Citation Analysis]
603 Wang X, He H, Lu Y, Ren W, Teng KY, Chiang CL, Yang Z, Yu B, Hsu S, Jacob ST, Ghoshal K, Lee LJ. Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog. Biochim Biophys Acta. 2015;1853:244-253. [PMID: 25447674 DOI: 10.1016/j.bbamcr.2014.10.017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
604 Zhao G, Zhang Y, Zhao Z, Cai H, Zhao X, Yang T, Chen W, Yao C, Wang Z, Wang Z, Han C, Wang H. MiR-153 reduces stem cell-like phenotype and tumor growth of lung adenocarcinoma by targeting Jagged1. Stem Cell Res Ther 2020;11:170. [PMID: 32375892 DOI: 10.1186/s13287-020-01679-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
605 Venkatesan BM, Bashir R. Nanopore sensors for nucleic acid analysis. Nature Nanotech 2011;6:615-24. [DOI: 10.1038/nnano.2011.129] [Cited by in Crossref: 924] [Cited by in F6Publishing: 737] [Article Influence: 92.4] [Reference Citation Analysis]
606 O'neill LA, Sheedy FJ, Mccoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 2011;11:163-75. [DOI: 10.1038/nri2957] [Cited by in Crossref: 593] [Cited by in F6Publishing: 583] [Article Influence: 59.3] [Reference Citation Analysis]
607 Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008;9:839-45. [PMID: 18645592 DOI: 10.1038/ni.f.209] [Cited by in Crossref: 776] [Cited by in F6Publishing: 788] [Article Influence: 59.7] [Reference Citation Analysis]
608 Overdevest JB, Theodorescu D, Lee JK. Utilizing the molecular gateway: the path to personalized cancer management. Clin Chem 2009;55:684-97. [PMID: 19246616 DOI: 10.1373/clinchem.2008.118554] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
609 Lerner C, Wemmert S, Bochen F, Kulas P, Linxweiler M, Hasenfus A, Heinzelmann J, Leidinger P, Backes C, Meese E, Urbschat S, Schick B. Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration. J Cancer Res Clin Oncol 2016;142:757-66. [PMID: 26621153 DOI: 10.1007/s00432-015-2087-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
610 Lee J, Choi K, Moon SU, Kim S. Theragnosis-based combined cancer therapy using doxorubicin-conjugated microRNA-221 molecular beacon. Biomaterials 2016;74:109-18. [DOI: 10.1016/j.biomaterials.2015.09.036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
611 Hua Z, Chun W, Fang-Yuan C. MicroRNA-146a and hemopoietic disorders. Int J Hematol 2011;94:224-9. [PMID: 21901398 DOI: 10.1007/s12185-011-0923-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
612 Mansueto G, Forzati F, Ferraro A, Pallante P, Bianco M, Esposito F, Iaccarino A, Troncone G, Fusco A. Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein. Genes Cancer 2010;1:210-24. [PMID: 21779448 DOI: 10.1177/1947601910366860] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
613 Carroll AP, Tooney PA, Cairns MJ. Context-specific microRNA function in developmental complexity. J Mol Cell Biol 2013;5:73-84. [PMID: 23362311 DOI: 10.1093/jmcb/mjt004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
614 Cao Z, Xu L, Zhao S. Exosome-derived miR-27a produced by PSC-27 cells contributes to prostate cancer chemoresistance through p53. Biochemical and Biophysical Research Communications 2019;515:345-51. [DOI: 10.1016/j.bbrc.2019.05.120] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
615 Sun B, Fang YT, Jin DJ, Chen ZY, Li ZY, Gu XD, Xiang JB. miR-194 Inhibits the Proliferation of SW620 Colon Cancer Stem Cells Through Downregulation of SSH2 Expression. Cancer Manag Res 2019;11:10229-38. [PMID: 31824193 DOI: 10.2147/CMAR.S221150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
616 Goeppert B, Truckenmueller F, Ori A, Fritz V, Albrecht T, Fraas A, Scherer D, Silos RG, Sticht C, Gretz N, Mehrabi A, Bewerunge-Hudler M, Pusch S, Bermejo JL, Dietrich P, Schirmacher P, Renner M, Roessler S. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p. Sci Rep 2019;9:4796. [PMID: 30886199 DOI: 10.1038/s41598-019-40857-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
617 Choi PJ, Oskouian RJ, Tubbs RS. The Current Understanding of MicroRNA's Therapeutic, Diagnostic, and Prognostic Role in Chordomas: A Review of the Literature. Cureus 2018;10:e3772. [PMID: 30820391 DOI: 10.7759/cureus.3772] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
618 Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology. 2008;47:1955-1963. [PMID: 18433021 DOI: 10.1002/hep.22256] [Cited by in Crossref: 497] [Cited by in F6Publishing: 470] [Article Influence: 38.2] [Reference Citation Analysis]
619 Stenvang J, Silahtaroglu AN, Lindow M, Elmen J, Kauppinen S. The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Seminars in Cancer Biology 2008;18:89-102. [DOI: 10.1016/j.semcancer.2008.01.004] [Cited by in Crossref: 133] [Cited by in F6Publishing: 119] [Article Influence: 10.2] [Reference Citation Analysis]
620 Grey F, Hook L, Nelson J. The functions of herpesvirus-encoded microRNAs. Med Microbiol Immunol 2008;197:261-7. [PMID: 18087721 DOI: 10.1007/s00430-007-0070-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
621 Perez-Hernandez J, Forner MJ, Pinto C, Chaves FJ, Cortes R, Redon J. Increased Urinary Exosomal MicroRNAs in Patients with Systemic Lupus Erythematosus. PLoS One. 2015;10:e0138618. [PMID: 26390437 DOI: 10.1371/journal.pone.0138618] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 13.0] [Reference Citation Analysis]
622 Saini S, Majid S, Dahiya R. Diet, microRNAs and prostate cancer. Pharm Res 2010;27:1014-26. [PMID: 20221895 DOI: 10.1007/s11095-010-0086-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
623 Pan Y, Wang N, Zhou Z, Liang H, Pan C, Zhu D, Liu F, Zhang CY, Zhang Y, Zen K. Circulating human cytomegalovirus-encoded HCMV-miR-US4-1 as an indicator for predicting the efficacy of IFNα treatment in chronic hepatitis B patients. Sci Rep 2016;6:23007. [PMID: 26961899 DOI: 10.1038/srep23007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
624 Tomaselli S, Panera N, Gallo A, Alisi A. Circulating miRNA profiling to identify biomarkers of dysmetabolism. Biomark Med. 2012;6:729-742. [PMID: 23227838 DOI: 10.2217/bmm.12.91] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
625 Sun K, Zeng T, Huang D, Liu Z, Huang S, Liu J, Qu Z. MicroRNA-431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1-mediated epithelial-mensenchymal transition. FEBS Open Bio 2015;5:900-7. [PMID: 26697292 DOI: 10.1016/j.fob.2015.11.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
626 Xiong T, Du Y, Fu Z, Geng G. MicroRNA-145-5p promotes asthma pathogenesis by inhibiting kinesin family member 3A expression in mouse airway epithelial cells. J Int Med Res 2019;47:3307-19. [PMID: 31264490 DOI: 10.1177/0300060518789819] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
627 Li BK, Huang PZ, Qiu JL, Liao YD, Hong J, Yuan YF. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma. Diagn Pathol. 2014;9:226. [PMID: 25466449 DOI: 10.1186/s13000-014-0226-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
628 Bosch-Presegué L, Vaquero A. The dual role of sirtuins in cancer. Genes Cancer 2011;2:648-62. [PMID: 21941620 DOI: 10.1177/1947601911417862] [Cited by in Crossref: 202] [Cited by in F6Publishing: 193] [Article Influence: 20.2] [Reference Citation Analysis]
629 Smith SM, Murray DW. An overview of microRNA methods: expression profiling and target identification. Methods Mol Biol 2012;823:119-38. [PMID: 22081343 DOI: 10.1007/978-1-60327-216-2_9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
630 Gadducci A, Guerrieri ME, Greco C. Tissue biomarkers as prognostic variables of cervical cancer. Crit Rev Oncol Hematol. 2013;86:104-129. [PMID: 23031678 DOI: 10.1016/j.critrevonc.2012.09.003] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 6.7] [Reference Citation Analysis]
631 Nahid MA, Satoh M, Chan EK. MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol. 2011;8:388-403. [PMID: 21822296 DOI: 10.1038/cmi.2011.26] [Cited by in Crossref: 194] [Cited by in F6Publishing: 199] [Article Influence: 19.4] [Reference Citation Analysis]
632 Alshehri B. Plant-derived xenomiRs and cancer: Cross-kingdom gene regulation. Saudi J Biol Sci 2021;28:2408-22. [PMID: 33911956 DOI: 10.1016/j.sjbs.2021.01.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
633 Shi Z, Kadeer A, Wang M, Wen B, Li M, Huang J, Gao Y, Liu E, Liu D, Jia D, Liang C. The deregulation of miR-133b is associated with poor prognosis in bladder cancer. Pathology - Research and Practice 2019;215:354-7. [DOI: 10.1016/j.prp.2018.11.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
634 Enriquez VA, Cleys ER, Da Silveira JC, Spillman MA, Winger QA, Bouma GJ. High LIN28A Expressing Ovarian Cancer Cells Secrete Exosomes That Induce Invasion and Migration in HEK293 Cells. Biomed Res Int 2015;2015:701390. [PMID: 26583126 DOI: 10.1155/2015/701390] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
635 Berkhout RP, Keijser R, Repping S, Lambalk CB, Afink GB, Mastenbroek S, Hamer G. High-quality human preimplantation embryos stimulate endometrial stromal cell migration via secretion of microRNA hsa-miR-320a. Hum Reprod 2020;35:1797-807. [PMID: 32644109 DOI: 10.1093/humrep/deaa149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
636 Wang J, Cao L, Wu J, Wang Q. Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma. Int J Oncol 2018;52:77-88. [PMID: 29115574 DOI: 10.3892/ijo.2017.4187] [Cited by in Crossref: 8] [Cited by in F6Publishing: 44] [Article Influence: 2.0] [Reference Citation Analysis]
637 Hong JH, Roh KS, Suh SS, Lee S, Sung SW, Park JK, Byun JH, Kang JH. The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients. Tumour Biol 2015;36:9327-37. [PMID: 26104764 DOI: 10.1007/s13277-015-3428-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
638 Neumann K, Gambardella A, Lilienkampf A, Bradley M. Tetrazine-mediated bioorthogonal prodrug-prodrug activation. Chem Sci 2018;9:7198-203. [PMID: 30288239 DOI: 10.1039/c8sc02610f] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 7.3] [Reference Citation Analysis]
639 Wang H, Guo Y, Tan G, Dong L, Cheng L, Li K, Wang Z, Luo H. miR-125b regulates side population in breast cancer and confers a chemoresistant phenotype: miR-125b R EGULATES S IDE P OPULATION. J Cell Biochem 2013;114:2248-57. [DOI: 10.1002/jcb.24574] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
640 Min L, Wang F, Hu S, Chen Y, Yang J, Liang S, Xu X. Aberrant microRNA-137 promoter methylation is associated with lymph node metastasis and poor clinical outcomes in non-small cell lung cancer. Oncol Lett 2018;15:7744-50. [PMID: 29740491 DOI: 10.3892/ol.2018.8273] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
641 Tang C, Zhou H, Zheng X, Zhang Y, Sha X. Dual Laplacian regularized matrix completion for microRNA-disease associations prediction. RNA Biol 2019;16:601-11. [PMID: 30676207 DOI: 10.1080/15476286.2019.1570811] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
642 Jayamohan S, Kannan M, Moorthy RK, Rajasekaran N, Jung HS, Shin YK, Arockiam AJV. Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer. Front Oncol 2019;9:847. [PMID: 31552174 DOI: 10.3389/fonc.2019.00847] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
643 Liu W, Xu G, Liu H, Li T. MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma. FEBS Lett 2015;589:3148-53. [PMID: 26341146 DOI: 10.1016/j.febslet.2015.08.034] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
644 Niu YW, Liu H, Wang GH, Yan GY. Maximal entropy random walk on heterogenous network for MIRNA-disease Association prediction. Math Biosci 2018;306:1-9. [PMID: 30336146 DOI: 10.1016/j.mbs.2018.10.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
645 Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 2008;283:1026-1033. [PMID: 17991735 DOI: 10.1074/jbc.m707224200] [Cited by in Crossref: 775] [Cited by in F6Publishing: 486] [Article Influence: 55.4] [Reference Citation Analysis]
646 Gao Y, Liu Z, Ding Z, Hou S, Li J, Jiang K. MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3. Oncol Lett 2018;15:4781-8. [PMID: 29552117 DOI: 10.3892/ol.2018.7976] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
647 Zhu Y, Liang S, Pan H, Cheng Z, Rui X. Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36. J Biosci 2018;43:365-73. [DOI: 10.1007/s12038-018-9755-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
648 Erturk E, Cecener G, Egeli U, Tunca B, Tezcan G, Gokgoz S, Tolunay S, Tasdelen I. Expression status of let-7a and miR-335 among breast tumors in patients with and without germ-line BRCA mutations. Mol Cell Biochem 2014;395:77-88. [PMID: 24942235 DOI: 10.1007/s11010-014-2113-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
649 Li N, Kaur S, Greshock J, Lassus H, Zhong X, Wang Y, Leminen A, Shao Z, Hu X, Liang S. A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer. Cancer Res. 2012;72:154-164. [PMID: 22058146 DOI: 10.1158/0008-5472.can-11-2484] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
650 Wang H, Tang C, Na M, Ma W, Jiang Z, Gu Y, Ma G, Ge H, Shen H, Lin Z. miR-422a Inhibits Glioma Proliferation and Invasion by Targeting IGF1 and IGF1R. Oncol Res 2017;25:187-94. [PMID: 28277190 DOI: 10.3727/096504016X14732772150389] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
651 Ma RR, Zhang H, Chen HF, Zhang GH, Tian YR, Gao P. MiR-19a/miR-96-mediated low expression of KIF26A suppresses metastasis by regulating FAK pathway in gastric cancer. Oncogene 2021;40:2524-38. [PMID: 33674746 DOI: 10.1038/s41388-020-01610-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
652 Susuki D, Kimura S, Naganuma S, Tsuchiyama K, Tanaka T, Kitamura N, Fujieda S, Itoh H. Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma. Cancer Sci. 2011;102:2164-2171. [PMID: 21899661 DOI: 10.1111/j.1349-7006.2011.02096.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
653 Sarver AL, Sarver AE, Yuan C, Subramanian S. OMCD: OncomiR Cancer Database. BMC Cancer 2018;18:1223. [PMID: 30522456 DOI: 10.1186/s12885-018-5085-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
654 Lv D, Bi Q, Li Y, Deng J, Wu N, Hao S, Zhao M. Long non‑coding RNA MEG3 inhibits cell migration and invasion of non‑small cell lung cancer cells by regulating the miR‑21‑5p/PTEN axis. Mol Med Rep 2021;23:191. [PMID: 33495842 DOI: 10.3892/mmr.2021.11830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
655 Wang XP, Yao J, Guan J, Zhou ZQ, Zhang ZY, Yang J. MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma. Biomed Pharmacother 2018;99:817-24. [PMID: 29710480 DOI: 10.1016/j.biopha.2018.01.131] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
656 Yan L, Yu M, Gao G, Liang H, Zhou X, Zhu Z, Zhang C, Wang Y, Chen X. MiR‐125a‐5p functions as a tumour suppressor in breast cancer by downregulating BAP1. J Cell Biochem 2018;119:8773-83. [DOI: 10.1002/jcb.27124] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 9.7] [Reference Citation Analysis]
657 Chen L, Han L, Zhang K, Shi Z, Zhang J, Zhang A, Wang Y, Song Y, Li Y, Jiang T, Pu P, Jiang C, Kang C. VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling. Neuro Oncol 2012;14:1026-36. [PMID: 22649212 DOI: 10.1093/neuonc/nos122] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 8.7] [Reference Citation Analysis]
658 Chen X, Niu YW, Wang GH, Yan GY. MKRMDA: multiple kernel learning-based Kronecker regularized least squares for MiRNA-disease association prediction. J Transl Med 2017;15:251. [PMID: 29233191 DOI: 10.1186/s12967-017-1340-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
659 Drahos J, Schwameis K, Orzolek LD, Hao H, Birner P, Taylor PR, Pfeiffer RM, Schoppmann SF, Cook MB. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium. Cancer Epidemiol Biomarkers Prev 2016;25:429-37. [PMID: 26604271 DOI: 10.1158/1055-9965.EPI-15-0161] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
660 Dong Y, Xiao Y, Shi Q, Jiang C. Dysregulated lncRNA-miRNA-mRNA Network Reveals Patient Survival-Associated Modules and RNA Binding Proteins in Invasive Breast Carcinoma. Front Genet 2019;10:1284. [PMID: 32010179 DOI: 10.3389/fgene.2019.01284] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
661 Du H, Xu Q, Xiao S, Wu Z, Gong J, Liu C, Ren G, Wu H. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Life Sci 2019;224:1-11. [PMID: 30876939 DOI: 10.1016/j.lfs.2019.03.028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 9.5] [Reference Citation Analysis]
662 Zhang R, Ma J, Yao J. Molecular mechanisms of the cartilage-specific microRNA-140 in osteoarthritis. Inflamm Res. 2013;62:871-877. [PMID: 23942573 DOI: 10.1007/s00011-013-0654-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
663 Zhou T, Chen S, Mao X. miR-145-5p affects the differentiation of gastric cancer by targeting KLF5 directly. J Cell Physiol 2019;234:7634-44. [PMID: 30367481 DOI: 10.1002/jcp.27525] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
664 Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4:143-159. [PMID: 22351564 DOI: 10.1002/emmm.201100209] [Cited by in Crossref: 1001] [Cited by in F6Publishing: 942] [Article Influence: 111.2] [Reference Citation Analysis]
665 Voccia D, Bettazzi F, Fratini E, Berti D, Palchetti I. Improving impedimetric nucleic acid detection by using enzyme-decorated liposomes and nanostructured screen-printed electrodes. Anal Bioanal Chem 2016;408:7271-81. [DOI: 10.1007/s00216-016-9593-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
666 Zheng D, Ding Y, Ma Q, Zhao L, Guo X, Shen Y, He Y, Wei W, Liu F. Identification of Serum MicroRNAs as Novel Biomarkers in Esophageal Squamous Cell Carcinoma Using Feature Selection Algorithms. Front Oncol. 2018;8:674. [PMID: 30719423 DOI: 10.3389/fonc.2018.00674] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
667 Zhang H, He QY, Wang GC, Tong DK, Wang RK, Ding WB, Li C, Wei Q, Ding C, Liu PZ, Cui HC, Zhang X, Li D, Tang H, Ji F. miR-422a inhibits osteosarcoma proliferation by targeting BCL2L2 and KRAS. Biosci Rep 2018;38:BSR20170339. [PMID: 29358307 DOI: 10.1042/BSR20170339] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
668 Liu L, Wang S, Chen R, Wu Y, Zhang B, Huang S, Zhang J, Xiao F, Wang M, Liang Y. Myc induced miR-144/451 contributes to the acquired imatinib resistance in chronic myelogenous leukemia cell K562. Biochemical and Biophysical Research Communications 2012;425:368-73. [DOI: 10.1016/j.bbrc.2012.07.098] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
669 Ghoshal-Gupta S, Kutiyanawalla A, Lee BR, Ojha J, Nurani A, Mondal AK, Kolhe R, Rojiani AM, Rojiani MV. TIMP-1 downregulation modulates miR-125a-5p expression and triggers the apoptotic pathway. Oncotarget 2018;9:8941-56. [PMID: 29507665 DOI: 10.18632/oncotarget.23832] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
670 Erdmann K, Kaulke K, Thomae C, Huebner D, Sergon M, Froehner M, Wirth MP, Fuessel S. Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs. BMC Cancer 2014;14:82. [PMID: 24517338 DOI: 10.1186/1471-2407-14-82] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
671 Constâncio V, Barros-Silva D, Jerónimo C, Henrique R. Known epigenetic biomarkers for prostate cancer detection and management: exploring the potential of blood-based liquid biopsies. Expert Rev Mol Diagn 2019;19:367-75. [PMID: 30961397 DOI: 10.1080/14737159.2019.1604224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
672 Li J, Song Y, Wang Y, Luo J, Yu W. MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells. Mol Cell Biochem. 2013;380:277-282. [PMID: 23670799 DOI: 10.1007/s11010-013-1682-y] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 8.3] [Reference Citation Analysis]
673 Xiao F, Bai Y, Chen Z, Li Y, Luo L, Huang J, Yang J, Liao H, Guo L. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. Eur J Cancer. 2014;50:1541-1554. [PMID: 24559685 DOI: 10.1016/j.ejca.2014.01.024] [Cited by in Crossref: 69] [Cited by in F6Publishing: 78] [Article Influence: 9.9] [Reference Citation Analysis]
674 Song C, Liu LZ, Pei XQ, Liu X, Yang L, Ye F, Xie X, Chen J, Tang H, Xie X. miR-200c inhibits breast cancer proliferation by targeting KRAS. Oncotarget 2015;6:34968-78. [PMID: 26392416 DOI: 10.18632/oncotarget.5198] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 9.6] [Reference Citation Analysis]
675 Incoronato M, Urso L, Portela A, Laukkanen MO, Soini Y, Quintavalle C, Keller S, Esteller M, Condorelli G. Epigenetic regulation of miR-212 expression in lung cancer. PLoS One 2011;6:e27722. [PMID: 22110741 DOI: 10.1371/journal.pone.0027722] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
676 Li SM, Wu HL, Yu X, Tang K, Wang SG, Ye ZQ, Hu J. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1. J Exp Clin Cancer Res 2018;37:219. [PMID: 30185212 DOI: 10.1186/s13046-018-0895-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
677 Sun Q, Liu T, Yuan Y, Guo Z, Xie G, Du S, Lin X, Xu Z, Liu M, Wang W, Yuan Q, Chen L. MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1. Int J Cancer 2015;136:1003-12. [PMID: 25044403 DOI: 10.1002/ijc.29065] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 10.0] [Reference Citation Analysis]
678 Zhou JN, Zeng Q, Wang HY, Zhang B, Li ST, Nan X, Cao N, Fu CJ, Yan XL, Jia YL. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4. Hepatology. 2015;62:801-815. [PMID: 25953743 DOI: 10.1002/hep.27887] [Cited by in Crossref: 90] [Cited by in F6Publishing: 100] [Article Influence: 15.0] [Reference Citation Analysis]
679 Feng J, Yang Y, Zhang P, Wang F, Ma Y, Qin H, Wang Y. miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb. J Cell Mol Med 2014;18:2125-34. [PMID: 25230975 DOI: 10.1111/jcmm.12398] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
680 Xu W, Ji J, Xu Y, Liu Y, Shi L, Liu Y, Lu X, Zhao Y, Luo F, Wang B. MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells. Mol Carcinog. 2015;54 Suppl 1:E148-E161. [PMID: 25252218 DOI: 10.1002/mc.22221] [Cited by in Crossref: 47] [Cited by in F6Publishing: 56]